Inventory of ICs

Inventory.pdf

Emergency Epidemic Investigation Data Collections - Expedited Reviews

Inventory of ICs

OMB: 0920-1011

Document [pdf]
Download: pdf | pdf
Form Approved
OMB No. 0920-1011
Exp. Date 03/31/2017

Questionnaire for Passengers and Crew
MERS-CoV Aircraft Contact Investigation

Public reporting burden of this collection of information is estimated to average 20 minutes per response, including the time for reviewing instructions,
searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not
conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. Send
comments regarding this burden estimate or any other aspect of this collection of information including suggestions for reducing this burden to
CDC/ATSDR Reports Clearance Officer; 1600 Clifton Road NE, MS D-74 Atlanta, Georgia 30333; ATTN: PRA (0920-1011)

DGMQ ID_Number______________
Questionnaire for Passengers and Crew, MERS-CoV Aircraft Contact Investigation
Identifying and Residency Information
1. Traveler’s name: _________________________________________________
2. Type of Traveler (circle):

passenger

crew

3. Home Phone: _________________________ 4. Mobile Phone: ____________________
(circle best number to reach at)
5. E-mail address: _________________________________
6. Home address (or address for next 14 days if nonresident): ____________________
______________________________________________________________________
7. State______________

8. Zip ____________

9. If non-US resident, country of residence: _________________________________
Attempt(s) to reach traveler:
Date

Time

Outcome

Message left/e-mail sent

Interview completed / not completed
Interview completed / not completed
Interview completed / not completed
Interview completed / not completed
Interview completed / not completed

Name of person answering the questions (if not traveler): ____________________________
Relationship of person answering questions to traveler: ____________________________
Name of Interviewer: ___________________________
Agency/Affiliation of Interviewer:______________________________________
Verbal consent/parental permission obtained? Circle: Yes / No

For serology? Yes / No

For minors (13-17): Assent obtained? Circle: Yes / No If NO, parent interviewed on
child’s behalf? Circle: Yes / No
Interview date (mm/dd/yy) ___/___/14

Assent for serology? Yes / No
Telephone

In-person

E-mail

Other _______
1

DGMQ ID_Number______________

A. Demographic Information
10. Age: ______ years / months (circle one)
11. Sex (circle one):

M

F

B. Flight History for Passenger (for crew member, skip to Section C)
The airline(s) has/have indicated that you were a passenger on the following flight(s). The next
set of questions pertain to that/those specific flight(s).
Questions 12-14 should be repeated for each flight, as applicable
NOTE: If passenger was not on any of the above flights, the interview is completed.
Questions for Flight(s)
12a. Confirm passenger traveled on [check flight(s) below]

o
o
o
o

Flight Leg A, May 1st, 2014
Flight Leg B, May 1st, 2014
Flight Leg C, May 1st, 2014
Flight Leg D, May 1st, 2014

Yes
Yes
Yes
Yes

No
No
No
No

Unsure
Unsure
Unsure
Unsure

If NO or unsure, provide code share info. Check other flights. If not on any of the flights,
then the interview is complete.
If YES,
13a: Did you sit in your assigned seat for this entire flight ?
Yes – Skip to Question 14a

No

Don’t remember

13a.1. If no, how long did you sit in your assigned seat?
<30 minutes

30-60 minutes

> 60 minutes

Don’t remember

13a.2. What other seat number did you sit in for all or part of the flight?
Seat Number: _______

Don’t remember

13a.3. If passenger doesn’t remember which seat number, ask to describe which part of
the plane she or he sat in. ________________________________________________
13a.4. How long did you sit in this other seat?
<30 minutes

30-60 minutes

> 60 minutes

Don’t remember
2

DGMQ ID_Number______________
14a. Were you traveling with anyone else on this flight?
Yes –complete table below

No – Skip to Question 14b

14.a.1. Who did you travel with? [This information will help make sure we can contact
her or him about possible exposure during the flight.]
Name (last, first)

Relation*

Phone

_______________________

_______________

______________

_______________________

_______________

______________

_______________________

________________

______________

*A. friend

B. colleague C. household member** D. non-household family member

** If household member(s), ask to interview that person when done with this interview

14b. Did you come into contact with anyone who seemed ill with respiratory symptoms (such
as cough or difficulty breathing) or appeared feverish?

Yes

No

14c. Did you assist them in any way? If yes, please explain.
_______________________________________________________________________
C. Flight History for Crew Member (For passenger, skip to Section D)
15. Confirm that crew member worked on

o
o
o
o

Flight Leg A, May 1st, 2014
Flight Leg B, May 1st, 2014
Flight Leg C, May 1st, 2014
Flight Leg D, May 1st, 2014

Yes
Yes
Yes
Yes

No
No
No
No

Unsure
Unsure
Unsure
Unsure

IF NO, interview is complete. Thank the person for her/his time.
If YES, continue
16. Crew type (circle all that apply) or Cabin for passenger
Flight Deck: Captain
First Officer
Flight engineer/ navigator
Other (such as jumpseater; specify): ________________________
Cabin:

First Class
Business Class
3

DGMQ ID_Number______________
Economy Class(specify section if assigned to a specific one): __________
Lead Flight Attendant

17. Did you come into contact with anyone who seemed ill with respiratory symptoms (such as
cough or difficulty breathing) or appeared feverish?

Yes

No

18. Did you assist them in any way? If yes, please explain.
_______________________________________________________________________
D. Illness and Medical History
19. Have you been ill since the day of the flight?

Yes

No

IF YES, GO TO 20. IF NO, GO TO APPENDIX I (SEROLOGY). THEN…



Read end script for asymptomatic contact.
Send Information Notice to traveler by e-mail or fax.

20. Have you had any of the following symptoms since your flight?
a. Fever (measured temp of > 100.40 F (380 C)
Yes (Temp if known _____°)
b. Coughing

Yes

No

No
Don’t Know

c. Difficulty breathing or shortness of breath
d. Wheezing

Yes

No

e. Pain with coughing or breathing
f. Other symptom(s):

Don’t Know

Yes

No

Don’t Know

Don’t Know
Yes

No

Don’t Know

Yes; List: ____________________

No

Don’t Know

IF NO/DON’T KNOW TO 20 a-e, GO TO APPENDIX I (SEROLOGY). THEN…
 Read end script for asymptomatic contact.
 Send Informational Notice for MERS-CoV Exposure on Airplane to traveler
by e-mail or fax.
21. What date did you first become ill with these symptoms? (Date : ____/____/14)
If sick on or before date of flight, complete interview, then consult medical officer
before giving advice to patient.
22. Are you still sick?

Yes

No

22a. If NO, when did you feel better? Date__/__/14
4

DGMQ ID_Number______________

23. Did you see a doctor for this illness?

Yes

No

If YES,
a. What date were you seen? Date__/__/14
b. Did you receive any treatment for the illness?

Yes

No

i. If YES, specify: _____________________________________
c. Were you tested by a medical provider for the illness (including, but not
limited to, providing a blood sample, or nasal or throat swab) since the day of
your flight?

Yes

No

i. If YES – Specify test or what kind of specimen was tested for you (e.g.,
blood, nasal swab, throat swab.): _______
1. Date (mm/dd/yy) ____/____/14
2. Facility where tested_____________________
d. Were you admitted to the hospital (kept overnight, not just in emergency
room)? YES/NO

If yes, which hospital? ________________

24. Do you have any medical conditions that you are treated for regularly?
Yes (Specify: ______________)
No
Don’t Know
25. For women: Are you currently pregnant?

Yes

No

Don’t Know

E. GEOGRAPHIC EXPOSURES
26. Have you visited the Middle East since April 17th?
Yes
No If NO, skip to Question 28.
a. If YES : Dates of visit (mm/dd/yy) ____/____/14 to ____/____/14
b. List country(ies): ___________________________
c. (Omit for crew) What was the purpose of your trip? (check all that apply)
Visit family/friends

Personal travel

Business

Study

Other, specify_______

27. While you were in the Middle East, did you:
a. Have any close contact with someone who was sick with MERS-Coronavirus?
Yes
No
b. Have any close contact with someone who was sick with a serious respiratory
infection, such as pneumonia? Yes
No
5

DGMQ ID_Number______________

c. Visit a health care facility?

Yes

No

d. (Omit for crew) Work in a health care facility?
e. Have any animal exposures?

Yes

Yes

No

No

If yes: name animals
1: ______________ (describe) ___________________, date:____/____/____
2: ______________ (describe) ___________________, date:____/____/___
3: ______________ (describe) ___________________, date:____/____/____

F. Household Contacts
28. Has anyone in your household or someone else you have had close contact with had
fever, cough, difficulty breathing, or other symptoms similar to what you described?
Yes ***

No

Don’t Know (*** Note this person’s name and contact information on the

form for follow-up by local health department.)

1. Name(s): ____________________________________
Relationship: __________________________________
Symptoms: _________________________________________
Date of onset (mm/dd/yy) ____/____/____
Address: ____________________________________________
Phone #: ________________________
2. Name: ____________________________________
Relationship: __________________________________
Symptoms: _________________________________________
Date of onset (mm/dd/yy) ____/____/____
Address: ____________________________________________
Phone #: ________________________

6

Form Approved 
OMB No. 0920‐1011 
Exp. Date 03/31/2017 

 
 
 
Serology Consent/Assent Script for Asymptomatic Passengers and Crew 
As part of our contact investigation we are asking passengers and crew to get a blood test for MERS.  
The test will help tell us if some people exposed to MERS can be infected without showing symptoms. 
This would involve drawing a small amount of blood (for adults 1 teaspoon, for infants or young children 
half a teaspoon or less). There will be no cost to you for doing this testing. Drawing blood can cause 
some pain, bruising or a small amount of bleeding at the site of the blood draw, and can make some 
people feel lightheaded.  
We will give you the results of the test, but they will not be available in time to make any decisions 
about your health care. Leftover blood will be stored at CDC and might be used for MERS testing in the 
future, such as developing new tests for MERS infection. If you agree to do the blood test, we will follow 
up with you at a later date (in approximately 2‐3 weeks) with more details about how and where to have 
your blood drawn. 
Do you have any questions? 
Would you be willing to let us do a MERS blood test?   Yes 

No 

If NO: thank the person for their time. 

Public reporting burden of this collection of information is estimated to average 5 per response, including the time for reviewing instructions, 
searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An 
agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid 
OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information including 
suggestions for reducing this burden to CDC/ATSDR Reports Clearance Officer; 1600 Clifton Road NE, MS D‐74 Atlanta, Georgia 30333; ATTN: 
PRA (0920‐1011) 

Case ID# ____________  

 

 

 

 

 

          Form Approved  
          OMB No. 0920‐1011 
          Exp. Date 03/31/2017                                        

 
Chart Abstraction Form – Legionnaires’ Disease 
SECTION I. SCREENING FOR SUSPECT LD CASES 
 
MRN:________________________________________________________________ 
 
Encounter (FIN): _______________________________________________________ 
 
Gender: _______ 
 
DOB: _______________ Age: _____ Race/Ethnicity: _____________________ 
 
Type of Residence:   □ Home     □ LTCF      □ Other ___________ 
 
Todays date: __ / __ / __ 
 
Date of admission:  __ / __ / __ 
 
Abstractors initials: ________ 
 
Did any of the following develop >48 hours of admission (do not count if present on 
admission)?  
 
1. Pneumonia symptoms? (Cough, shortness of breath) 
 
□ Yes  □ No (if yes, then con nue to Sec on II) 
 
2. Abnormal CXR / CT suggestive of pneumonia/infiltrate? 
 
□ Yes  □ No (if yes, then con nue to sec on II) 
 
3. Was another etiology identified (other than Legionella)? 
□ Yes  □ No (if yes, then stop) 
 
 
 
 
 
 
 
 

Page 1 of 8 
Public reporting burden of this collection of information is estimated to average 90 minutes per response, including the time for
reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the
collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of
information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other
aspect of this collection of information including suggestions for reducing this burden to CDC/ATSDR Reports Clearance Officer;
1600 Clifton Road NE, MS D-74 Atlanta, Georgia 30333; ATTN: PRA (0920-1011)

Case ID# ____________  

 

 

 

 

 

           

 
SECTION II. TYPE OF CASE 
Information Source (check all that apply): 
□ hospital chart 
□ other (if other specify) ______________ 
 
1. Type of exposures to Hospital A during incubation period (check all that apply):   
□ Inpa ent    □ Outpa ent     □ Visitor      □Volunteer    □Employee 
 
2. Case definition: 
       □ Confirmed Case           □ Suspected Case          □ Possible Case          □ Subclinical case 
 
3. Case Classification:  
       □ Definitely outbreak‐associated          □ Possibly outbreak‐associated  
       □ Non‐outbreak associated 
 
If non‐outbreak‐associated, END HERE.  Otherwise, continue to next page. 
 
 
 
SECTION III. LEGIONELLA‐SPECIFIC TESTING 

  

1. Respiratory specimen collected and processed specifically for Legionella culture?  
_____ Yes   ______ No   _____ Unknown 
 
a.) If YES, 
Specimen type: (e.g., expectorated sputum, BAL, etc.) __________________ 
Collected Date: ____/____/ ____ Laboratory Name:____________________ 
Results:________________________________________________________ 
 
b.) If NO, 
Respiratory specimen collected for any culture? 
 _____ Yes     ______ No   _____ Unknown 
If Yes, 
Specimen type: (e.g., expectorated sputum, BAL, etc.) ____________________ 
Collected Date: ____/____/ ____ Laboratory: ___________________________ 
Results:__________________________________________________________ 
 
2. Urine specimen collected for Legionella urine antigen testing?  
_____ Yes 
______ No 
  _____ Unknown 
Collected Date: ____/____/ ____ Laboratory Name: ________________________ 
Results: ____________________________________________________________ 
 
3. Other  Legionella testing? ________________________________________________ 
 
SECTION IV. MEDICAL HISTORY 
 
Page 2 of 8 

Case ID# ____________  

 

 

 

 

 

           

 
□ COPD/Emphysema/Chronic Lung Disease 
 
□ Diabetes 
 
□ Conges ve Heart Failure 
 
□ History of stroke/CVA 
 
□ Chronic Renal Insuffiency (CRI/CKD) or End‐Stage Renal Disease (ESRD) 
 
□ Cirrhosis / Liver Disease 
 
□ Cancer  (Type: ________________; Date of diagnosis __/__/__) 
 
□ Organ Transplant (Type:__________________) Date of transplant: __ / __ / __ 
 
□ Bone Marrow Transplant; Date of transplant: __ / __ / __ 
 
□ HIV/AIDS, CD4 count: ____________  Date: __ / __ / __ 
 
□ Dementia  
 
□ Taking systemic steroid 
 
□ History of chemotherapy  Date: __ / __ / __ (Is this 1st cycle of induction chemo?   □  Yes        □  No)          
 
□ History of radiation  Date: __ / __ / __ 
 
□ History of pneumonia in prior year, Date: __ / __ / __ 
 
□ Other (___________________________) 
 
□ Other (___________________________) 
 
History of smoking:  □  Yes          □  No          □  Unknown 
          If yes:  □  Current          □  Former          □  Unknown 
 
History of alcohol abuse: □  Yes          □  No          □  Unknown 
 
History of other substance abuse:  □  Yes          □  No          □  Unknown 
          Specify substance(s): _________________________________ 
 
 

Page 3 of 8 

Case ID# ____________  

 

 

 

 

 

           

 
 
SECTION V. SIGNS AND SYMPTOMS 
□ Shortness of breath; Date of onset: __ / __ / __ 
 
□ Cough; Date of onset: __ / __ / __ 
 
□ Fever >100.5°F; Date of onset: __ / __ / __ 
 
□ Diarrhea (3 stools/24h); Date of onset: __ / __ / __ 
 
□ Nausea or Vomiting; Date of onset: __ / __ / __ 
 
□ Confusion (altered mental status); Date of onset: __ / __ / __  
 
□ Other (____________);Date of onset: __ / __ / __ 
 
□ Other (____________);Date of onset: __ / __ / __ 
 
BEST SYMPTOM ONSET DATE: __  / __  / __ 
(If the patient did not have prior respiratory symptoms, choose, the onset date of cough or 
shortness of breath, whichever occurs first. Otherwise, use the earliest date when other 
symptoms suggestive of Legionella infection began.)  
 
SECTION VI. RADIOGRAPHIC FINDINGS 
 
Document any radiographic findings 14 days after onset of symptoms above. If multiple chest 
images are available, report the first for which evidence of pneumonia is noted. 
 
□ Chest X‐ray 
If Yes, when and what were the findings? 
Date: ____/____ / _____ 
□ Normal  
 
□ Abnormal 
Result:   
□ New Infiltrate    □ Old / Unchanged Infiltrate     □ Indeterminate      □ Consolida on      
□ No infiltrate      □ Not available / Unknown 
Findings (impression): _____________________________________________________ 
 
 
 
□ CT Scan 
If Yes, when and what were the findings? 
Date: ____/____ / _____ 
□ Normal  
 
□ Abnormal 
Result:   
□ New Infiltrate    □ Old / Unchanged Infiltrate     □ Indeterminate      □ Consolida on      
□ No infiltrate      □ Not available / Unknown 
Findings (impression): _____________________________________________________ 
Page 4 of 8 

Case ID# ____________  

 

 

 

 

 

           

 
 
 
SECTION VII. VITAL SIGNS  
 
Highest O2 demand (FiO2): _______________________  Date (earliest):__________________ 
 
Pulse ox (lowest recorded): ________________   
Date: _____________________ 
Tmax: _____________________  
 
 
Date ______________________ 
 
 
 
SECTION VIII. LABORATORY VALUES 
 
TEST 
Result 
Date 
WBC (lowest) 
 
____ / ____ / ____ 
% Neutrophils  
____ / ____ / ____
% Lymphocytes  
____ / ____ / ____
WBC (highest) 
 
____ / ____ / ____
Hemoglobin (lowest) 
 
____ / ____ / ____
Platelets (lowest) 
 
____ / ____ / ____
Na (lowest) 
 
____ / ____ / ____
Cr (highest) 
 
____ / ____ / ____
Required dialysis □ Yes     □ No 
 
AST (highest) 
 
____ / ____ / ____
ALT (highest) 
 
____ / ____ / ____
Total bilirubin (highest) 
 
____ / ____ / ____
Ferritin (highest) 
 
____ / ____ / ____
CRP (highest) 
 
____ / ____ / ____
ESR (highest) 
 
____ / ____ / ____
 
 
SECTION IX. INVASIVE PROCEDURES 
 
Document procedures done 14 days prior to the onset of symptoms above 
 
Procedure name 
Date 
□ NG/OG tube placement 
____ / ____ / ____
□ ET/OT/Other Intubation 
____ / ____ / ____
□ Lumbar puncture 
____ / ____ / ____
□ Thoracentesis 
____ / ____ / ____
□ Paracentesis 
____ / ____ / ____
□ Bronchoscopy 
____ / ____ / ____
□ Central line placement 
____ / ____ / ____
□ Arterial line placement 
____ / ____ / ____
□ Other___________________  ____ / ____ / ____ 
□ Other___________________  ____ / ____ / ____ 
 
Page 5 of 8 

Case ID# ____________  

 

 

 

 

 

           

 
 
SECTION X. ANTIBIOTICS / IMMUNOSUPPRESION REGIMENS 
 
Dose 
Route 
Start Date 
Antibiotic / 
immunosuppressive 
therapy 
□ Levofloxacin 
 
 
 
(Levoquin) 
□ Moxifloxacin 
 
 
 
□ Ciprofloxacin 
 
 
 
(Cipro) 
□ Azithromycin 
 
 
 
(Zithromax) 
□ Erythromycin 
 
 
 
 
□ Rifampin 
 
 
 
□ Rifapentine 
 
 
 
□ Linezolid 
 
 
 
□ Tetracycline 
 
 
 
□ Doxycycline 
 
 
 
□ Quinupristin/ 
 
 
 
dalfopristin (Synercid) 
 
 
 
□ Chemotherapy 
regimen (specify): 
___________ 
□ Radiation therapy 
 
 
 
(specify): 
___________ 
□ Systemic steroids 
 
 
 
(specify): 
___________ 
Other (specify): 
 
 
 
___________ 
Other (specify): 
 
 
 
___________ 
Other (specify): 
 
 
 
___________ 
Other (specify): 
 
 
 
___________ 

End Date 

 

Check if 
continued as 
outpatient 
 

 
 

 
 

 

 

 

 

 
 
 
 
 
 

 
 
 
 
 
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Page 6 of 8 

Case ID# ____________  

 

 

 

 

 

           

 
 
SECTION XI. CLINICAL OUTCOMES 
 
□ ICU Stay 
a.) If ICU stay, 
a. Number of days in ICU: __________ (count days where any time was spent in 
ICU)  
 
DISPOSITION: 
□ S ll Hospitalized   
□ Transferred to another facility (list:________________________________________)    
□ Discharged Home 
□ Unknown    
□ Deceased      
 
b.) If deceased, 
a. Date of death: __________ (mm/dd/yyyy)  
b. Was a post‐mortem examination performed? ___Yes ___No ____Unknown 
i. If yes, are tissue specimens available? ____ Yes ____No ____ Unknown
 
DISCHARGE DIAGNOSIS 
□ Legionellosis 
 
□ Pneumonia   
If yes,  Etiology: ____________________ Lab Test(s): _______________________ 
 
□ Other Dx: _________________________________________________________________ 
 
 
 

Page 7 of 8 

Case ID# ____________  

 

 

 

 

 

           

 
 
SECTION XII. EXPOSURES 
 
□ Hospitalized before; Date of admission: __ / __ / ____ ; Date of Discharge: __ / __ / ____ 
              □ ICU stay; if yes # of days in ICU___________ days 
              □ Intubated 
              Discharge diagnosis: □ Legionellosis     □ Pneumonia; e ology:_____________________
 
                                                    □ Other diagnosis; specify: _______________________________ 
 
□ Hospitalized before; Date of admission: __ / __ / ____ ; Date of Discharge: __ / __ / ____ 
              □ ICU stay; if yes # of days in ICU___________ days 
              □ Intubated 
              Discharge diagnosis: □ Legionellosis     □ Pneumonia; e ology:_____________________
 
                                                    □ Other diagnosis; specify: _______________________________ 
 
□ Hospitalized before; Date of admission: __ / __ / ____ ; Date of Discharge: __ / __ / ____ 
              □ ICU stay; if yes # of days in ICU___________ days 
              □ Intubated 
              Discharge diagnosis: □ Legionellosis     □ Pneumonia; etiology:_____________________
 
                                                    □ Other diagnosis; specify: _______________________________ 
 
OUTPATIENT VISITS to Hospital A or associated clinics (including rehab visits) 
 
Did patient have any outpatient visits during the 2‐10 days prior to symptom onset?  
_____ Yes  _____ No _____ Unknown 
 
If yes, list location of visits and name of clinic: 
 
Building 
Room# 
Date(s) of Visit 
Name of 
Clinic 
Campus 
(e.g., Primary Care, 
Cardiology) 
 
 
 
 
 
 

 

 

 

 

 

 

 

 

 

 

 

Page 8 of 8 

 

June 11, 2014 
Form Approved
OMB No. 0920‐1011
Exp. Date 03/31/2017

Hypothesis Generating Questionnaire
Gastroenteritis

 

1

 

June 11, 2014 
Form Approved
OMB No. 0920‐1011
Exp. Date 03/31/2017

Outbreak of Diarrheal Illness in American Samoa:
Hypothesis Generating Questionnaire for Gastroenteritis Complaints
Hi! My name is
. We are working with the Health department
to try and figure out what caused the outbreak of diarrhea. Could we please ask you a few
questions? Your answers will help prevent diarrhea in the future.
Your answers will be completely confidential. That means we will not share your personal
information with anybody else.
Thank you!!!
1) INTERVIEWER INFORMATION:
Interviewer name:
Date:
2) DEMOGRAPHIC INFORMATION:
Patient name:
Name (if not the patient):
Relationship to child (if patient is <18 years of age):
Sex:

M

F

DOB:
Nationality:
American Samoan
Western Samoan
Other Pacific Islander
Asian
White, non-Hispanic
Black, non-Hispanic
Unknown
Name of Village:
Number of people in household:
Number of adults:
Number of children:
 

2

 

June 11, 2014 
Form Approved
OMB No. 0920‐1011
Exp. Date 03/31/2017

Place of work:_
3) CLINICAL SYMPTOMS:
According to our records, you came to the Emergency room for diarrhea on (DATE). Please
think back to the week before you got sick.
When did you first get sick (mm/dd/yyyy)?
On what day did diarrhea begin (mm /dd /yyyy)?
For how many days did you experience diarrhea? :
When at its worst, what was the total number of episodes of diarrhea you experienced in a 24
hour period?
- 1-3 per day
- 4-6 per day
- 5-10 per day
- 10+ per day
What symptoms did you have? : Circle all that apply.
- Fever
- Vomiting
- Poor feeding
- Irritable
- Bloody diarrhea
- Non-bloody diarrhea
- Watery diarrhea
- Fatigue/Weakness
- Chills
- Headache
- Abdominal cramps
- Nausea
- Bodyaches
What was the first place you went to seek treatment?
- Emergency room
- Local clinic
- Village healer
- Other:
 

3

 

June 11, 2014 
Form Approved
OMB No. 0920‐1011
Exp. Date 03/31/2017

Did you take any medications for the diarrhea?
Over the counter:
From the hospital:

Yes
Yes

No
No

/Name:
/Name:

Do you use any at-home remedies for diarrhea?

Yes

No /Name:

Did you hear about diarrhea from family/friends recently?

Yes

No

Did you hear about diarrhea from on TV/in the newspaper recently?

Yes

No

How long after you first got sick did you seek medical treatment?
- Less than 1 day
- 1 – 2 days
- 3 – 4 days
- 5 – 6 days
- 7 days or more
What prompted you to go to the emergency room? Circle all that apply.
- Diarrhea
- Dehydration
- Fever
- Stomach / gut pain
- Unable to eat
- To get medicine
- Worried about ameba
- Friend or family member suggested going
- Other:
4) TRAVEL / EVENT EXPOSURES:
Did you attend flag day?

Yes

No

In the week before illness, did you travel anywhere outside the village?

Yes

No

If yes, where?
Other village(s): (Village name(s):
Off-island (Name of location):
In the week before illness, did you have contact with anyone who traveled:
Outside the village: Yes No
Off-island: Yes No
 

4

 

June 11, 2014 
Form Approved
OMB No. 0920‐1011
Exp. Date 03/31/2017

In the week before illness, were you exposed to a school or child-care facility?
In the week before illness, were you exposed to any flies?
Is your home screened? Yes

Yes

Yes

No

No

Do you have a refrigerator? Yes

No

In the week before illness, did you attend any special events where food was served or catered
(weddings, community meetings, church events, etc.)? Yes No
If yes:
#1 Type of event:
#1 Was there a sink with soap and water to wash your hands? Yes No
#2 Type of event:
#2 Was there a sink with soap and water to wash your hands?

Yes

No

In the week before illness, did you go swimming or have other recreational water exposures
(fishing, etc.)? Yes No
If yes, please describe:

5) HOUSEHOLD WATER EXPOSURES:
What is the water supply source for your home or residence? Circle all that apply.
- ASPA water
- Village water
- Rain water
- Vending machines
- Bottled water
- Other:
If multiple sources, what source is usually used for each?
Drinking:
Cooking:
Bathing:
Washing clothing:
Cleaning:
washing:
 

Hand

5

 

June 11, 2014 
Form Approved
OMB No. 0920‐1011
Exp. Date 03/31/2017

Where do you typically wash your hands at home?

When do you typically wash your hands at home?

When you don’t wash your hands at home, what are some reasons why?

Does the household usually boil or filter water before use for cooking?
- Boiling
- Filtering
- No treatment
Does the household usually boil or filter water before use for drinking?
- Boiling
- Filtering
- No treatment
6) SEWAGE EXPOSURES:
What type of sewage disposal does your house have?
- ASPA sewage
- Septic Tank
- Cesspool
- Nothing
- Other :
41. How do you dispose of trash?
- ASPA
- Self-disposal
- Other:
IF ASPA:
How many days per week is trash collected by ASPA?
days per week
IF SELF DISPOSAL:
How many days per week is trash taken outside the house?
 

6

 

June 11, 2014 
Form Approved
OMB No. 0920‐1011
Exp. Date 03/31/2017

days per week
How many days per week is trash taken off the property?
days per week
Where do you take the trash to:
7) FOOD EXPOSURES:
What do you eat on a typical day?
Breakfast
What do you eat?

Where do you eat?
Lunch
What do you eat?

Where do you eat?
Dinner
What do you eat?

Where do you eat?
Snacks
What do you eat?

Where do you eat?
Drinks
What do you drink?

Where do you usually shop for groceries?
 

7

 

June 11, 2014 
Form Approved
OMB No. 0920‐1011
Exp. Date 03/31/2017

What restaurants do you usually go to?

8) ILL CONTACTS:
Do you know anyone else who is ill? Yes No
#1 Relation to you:
#1 Does this person live with you?:
#1 Village:
#2 Relation to you:_
#2 Does this person live with you?:
#2 Village:
#3 Relation to you:_
#3 Does this person live with you?:
#3 Village:
#4 Relation to you:
#4 Does this person live with you?:
#4 Village:
#5 Relation to you:
#5 Does this person live with you?:
#5 Village:
9) PERSONAL OPINION
How do you think you got sick?

Is there anything else you would like to share with us, relating to the diarrhea outbreak?

THANK YOU SO MUCH FOR YOUR TIME!!!
We truly appreciate your talking to us today.

 

8

Form Approved
OMB No. 0920-1011
Exp. Date 03/31/2017

Household Line Listing
Measles

Public reporting burden of this collection of information is estimated to average 55 minutes per response, including the time for reviewing
instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of
information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a
currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information
including suggestions for reducing this burden to CDC/ATSDR Reports Clearance Officer; 1600 Clifton Road NE, MS D-74 Atlanta, Georgia
30333; ATTN: PRA (0920-1011)

Measles Case ID # ________

Number of Persons Living in the House _____

1

2

3

4

5

6

7

8

Date of
Birth

__ /_ __/_ __

__ /_ __/_ __

__ /_ __/_ __

__ /_ __/_ __

__ /_ __/_ __

__ /_ __/_ __

__ /_ __/_ __

__ /_ __/_ __

Age
(y, m)

Number of Rooms in the House ____

Sex

__ _/__ _/__ _

HH No.

List Dates of HH Visits __ _/__ _/__ _

First Name
Last Name

1

Case-Patient’s Name ________________________________
__ _/__ _/__ _

Mother’s First
Name (If age
39 or less)

Fever and
rash in the
last 2
months
(May/June)?
Yes
Date of onset
__ _/__ _/__ _
No
Yes
Date of onset
__ _/__ _/__ _
No
Yes
Date of onset
__ _/__ _/__ _
No
Yes
Date of onset
__ _/__ _/__ _
No
Yes
Date of onset
__ _/__ _/__ _
No
Yes
Date of onset
__ _/__ _/__ _
No
Yes
Date of onset
__ _/__ _/__ _
No
Yes
Date of onset
__ _/__ _/__ _
No

Household Location: Municipality _______________

Had
measles
before
this
year?
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No

MMR
Doses
0___
1___
2___
3___
0___
1___
2___
3___
0___
1___
2___
3___
0___
1___
2___
3___
0___
1___
2___
3___
0___
1___
2___
3___
0___
1___
2___
3___
0___
1___
2___
3___

MMR
Dates

Doses
obtained
(check one)

__ _/_ __/_ __
__ _/_ __/_ __
__ _/_ __/_ __

__ by history
__ from record

__ _/_ __/_ __
__ _/_ __/_ __
__ _/_ __/_ __

_ by history
_ from record

__ _/_ __/_ __
__ _/_ __/_ __
__ _/_ __/_ __

_ by history
_ from record

__ _/_ __/_ __
__ _/_ __/_ __
__ _/_ __/_ __

_ by history
_ from record

__ _/_ __/_ __
__ _/_ __/_ __
__ _/_ __/_ __

_ by history
_ from record

__ _/_ __/_ __
__ _/_ __/_ __
__ _/_ __/_ __

_ by history
_ from record

__ _/_ __/_ __
__ _/_ __/_ __
__ _/_ __/_ __

_ by history
_ from record

__ _/_ __/_ __
__ _/_ __/_ __
__ _/_ __/_ __

_ by history
_ from record

Village _______________

Lived/slept at least one night
in the HH from 3 days prior
and 3 days after rash onset of
1st case?
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No

9

10

11

12

13

14

15

16

17

2

Case-Patient’s Name ________________________________

Date of
Birth

__ /_ __/_ __

__ /_ __/_ __

__ /_ __/_ __

__ /_ __/_ __

__ /_ __/_ __

__ /_ __/_ __

__ /_ __/_ __

__ /_ __/_ __

__ /_ __/_ __

Age
(y, m)

First Name
Last Name

Sex

HH No.

Measles Case ID # ________

Mother’s First
Name (If age
39 or less)

Fever and
rash in the
last 2
months
(May/June)?
Yes
Date of onset
__ _/__ _/__ _
No
Yes
Date of onset
__ _/__ _/__ _
No
Yes
Date of onset
__ _/__ _/__ _
No
Yes
Date of onset
__ _/__ _/__ _
No
Yes
Date of onset
__ _/__ _/__ _
No
Yes
Date of onset
__ _/__ _/__ _
No
Yes
Date of onset
__ _/__ _/__ _
No
Yes
Date of onset
__ _/__ _/__ _
No
Yes
Date of onset
__ _/__ _/__ _
No

Had
measles
before
this
year?
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No

MMR
Doses
0___
1___
2___
3___
0___
1___
2___
3___
0___
1___
2___
3___
0___
1___
2___
3___
0___
1___
2___
3___
0___
1___
2___
3___
0___
1___
2___
3___
0___
1___
2___
3___
0___
1___
2___
3___

MMR
Dates

Doses
obtained
(check one)

__ _/_ __/_ __
__ _/_ __/_ __
__ _/_ __/_ __

_ by history
_ from record

__ _/_ __/_ __
__ _/_ __/_ __
__ _/_ __/_ __

__ by history
__ from record

__ _/_ __/_ __
__ _/_ __/_ __
__ _/_ __/_ __

_ by history
_ from record

__ _/_ __/_ __
__ _/_ __/_ __
__ _/_ __/_ __

_ by history
_ from record

__ _/_ __/_ __
__ _/_ __/_ __
__ _/_ __/_ __

_ by history
_ from record

__ _/_ __/_ __
__ _/_ __/_ __
__ _/_ __/_ __

_ by history
_ from record

__ _/_ __/_ __
__ _/_ __/_ __
__ _/_ __/_ __

_ by history
_ from record

__ _/_ __/_ __
__ _/_ __/_ __
__ _/_ __/_ __

_ by history
_ from record

__ _/_ __/_ __
__ _/_ __/_ __
__ _/_ __/_ __

_ by history
_ from record

Lived/slept at least one night
in the HH from 3 days prior
and 3 days after rash onset of
1st case?
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No

18

3

Case-Patient’s Name ________________________________

Date of
Birth

__ /_ __/_ __

Age
(y, m)

First Name
Last Name

Sex

HH No.

Measles Case ID # ________

Mother’s First
Name (If age
39 or less)

Fever and
rash in the
last 2
months
(May/June)?
Yes
Date of onset
__ _/__ _/__ _
No

Had
measles
before
this
year?
Yes
No

MMR
Doses
0___
1___
2___
3___

MMR
Dates

__ _/_ __/_ __
__ _/_ __/_ __
__ _/_ __/_ __

Doses
obtained
(check one)

_ by history
_ from record

Lived/slept at least one night
in the HH from 3 days prior
and 3 days after rash onset of
1st case?
Yes
No

Form Approved
OMB No. 0920-1011
Exp. Date 03/31/2017

Dengue and chikungunya report form

Public reporting burden of this collection of information is estimated to average 5 minutes per response, including the time for
reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing
the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of
information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other
aspect of this collection of information including suggestions for reducing this burden to CDC/ATSDR Reports Clearance Officer;
1600 Clifton Road NE, MS D-74 Atlanta, Georgia 30333; ATTN: PRA (0920-1011)

DENGUE & CHIKUNGUNYA REPORT FORM
U.S. Virgin Islands Department of Health
Charles Harwood Complex, 3500 Estate Richmond
Christiansted, St. Croix, USVI 00820-4370
Tel. (340) 773-1311 x3241, Fax (340) 718-1508

Case number

Specimen #

SAN ID

GCODE

Days post onset (DPO) Type

Date Received

S3

S2

S4

No

Today’s date: _______________
Day/Month/Year

Specimen #

S1

SUSPECTED CHIK? Yes

Days post onset (DPO)

Type

Date Received

Please read and complete ALL sections
Patient Data

Hospitalized due to this illness: No

→ Hospital Name:

Yes

Record Number:
Fatal:

Name of Patient:
Last Name

First Name

Yes

Middle Name or Initial

No

Unk

Mental status changes:

If patient is a minor, name of father or primary caregiver:
Last Name

First Name

Home (Physical) Address

Middle Name or Initial

Yes

No

Unk

Physician who referred this case

Home address here

Name of Healthcare Provider:
Tel:

Fax:

Email:

Do you want to receive laboratory results via Fax or Email?
City:

Zip code:

Tel:

-

Other Tel:

Residence is close to:
Work address:

Patient’s Demographic Information

Date of Birth:

Age:

months Sex:

or Age:

years

Who filled out this form?
M

F

Pregnant: Y

N

UNK

Weeks pregnant (gestation):

Day/Month/Year

Name (complete)
Relationship with patient:
Tel:

Fax:

Email:

Must have the following information for sample processing
Day/Month/Year

Country of birth

How long have you lived in this city?

Date of first symptom:

During the 14 days before onset of illness, did you TRAVEL to other cities or countries?

Date specimen taken:
First sample

Yes, another country

Yes, another city

No

Unknown

WHERE did you TRAVEL?

Second sample

Are there any sick contacts in your household?
Yes

No

PLEASE indicate below the signs and symptoms that the patient had at the time of illness
Yes

No

Unk

Evidence of capillary leak
Lowest

Fever lasting 2-7 days……………......
Fever (>38ºC/101ºF)………………......
Platelets ≤100,000/mm3………..….....

Warning signs

hematocrit

Highest

hematocrit

Lowest

serum

(%)

Persistent vomiting...................................

(%)

Abdominal pain/Tenderness…………..

albumin

Mucosal bleeding …………………….....

Lowest serum protein

Lethargy, restlessness……….…………...

Platelet count:

Lowest blood pressure (SBP/DBP)

Any hemorrhagic manifestation
Petechiae………………………..

Lowest pulse pressure (systolic - diastolic)

Liver enlargement >2cm………………..

/

Pleural or abdominal effusion………….

Lowest white blood cell count (WBC)

Purpura/Ecchymosis…………..

Symptoms

Yes

Yes

Additional symptoms
No

Unk

Diarrhea……………………………...……..

Vomit with blood……………….

Rapid, weak pulse……………...

Blood in stool……………………

Cough…………………………………….…

Pallor or cool skin……………….

Nasal bleeding…………………

Conjunctivitis……………………………....

Chills………………………….……

Nasal congestion…………………………

Rash…...........................................

Sore throat………………………………....

Headache……………….……….

Jaundice………………………..................

Eye pain…………………………..

Convulsion or coma……………………..

Body (muscle/bone) pain…….

Nausea and vomiting (occasional)…..

Joint pain…………………………

Arthritis (Swollen joints)…………………..

Anorexia……………………….....

Missed school/work due to this illness.

Bleeding gums………………….
Blood in urine…………………...
Vaginal bleeding………………
Positive urinalysis……………....
(over 5 RBC/hpf or positive for blood)
Tourniquet test

Pos

Neg

Not done

Unable to walk during this illness……..

No

Unk

Form Approved
OMB No. 0920-1011
Expiration 03/31/2017
Suspected Chikungunya Case Questionnaire

August 16, 2014

Interviewer:______________ Date of Interview: ___/___/_____
Name of person/parent giving consent:_____________________ □ Refused Interview
If case-patient is not available, ask for an alternate contact number or time to call back to speak with case
patient. Alternate number _______________ Alternate day/time _________________

1.) We have your age (your child’s age) as ______, is this correct? [If no] What is the correct age? ____
a. [For parents <17 year old child] Can I ask what is your age and sex?
Age in years____ Sex: □ Male □ Female
2.) Per our records, a sample was taken for chikungunya testing on __ __ /__ __ /2014 , does this sound correct?
□ Yes □ No
[If this is not correct] Can you recall which date the sample was drawn? __ __ /__ __ /2014
3.) Besides yourself (or your child), has anyone else in your household had similar symptoms?
□ Yes (go to question 4)
□ No (go to question 5)
□ Don’t know (go to question 5)
4.) How many of these household members with similar symptoms sought medical care? _______
5.) How long did the initial joint pain last when you were tested for Chikungunya? _________ days after
symptoms started.
6.) Do you have any joint pain (i.e., pain in your wrists, ankles, hands or feet) or joint swelling today that you
think might be related to your recent illness?
□ Yes (go to question 8)
□ No (go to question 7)
□ Don’t know (go to question 7)
7.) Have you (or your child) had any joint pain or swelling in the last week that you think might be related to your
recent illness?
□ Yes (go to question 8)
□ No (go to question 9)
□ Don’t know
8.) How often do you (your child) experience joint pain or swelling that you think might be related to your recent
illness?
□ Daily
□ Two to three times per week
□ Once per week
□ Less than once per week
□ Don’t know

Public reporting burden of this collection of information is estimated to average 10 minutes per response, including the time for reviewing instructions, 
searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may 
not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. 
Send comments regarding this burden estimate or any other aspect of this collection of information including suggestions for reducing this burden to 
CDC/ATSDR Reports Clearance Officer; 1600 Clifton Road NE, MS D‐74 Atlanta, Georgia 30333; ATTN: PRA (0920‐1011) 

9.) What is your current employment status?

□ Working (go to question 10)
□ Retired (go to question 13)
□ Not Working (go to question 13)
□ Child (go to question 15)
□ Refused

10.) In the time since you have visited the doctor for suspected chikungunya, have you missed time from work
because of your illness?
□ Yes (go to question 11)
□ No (go to question 16)
11.) Have you (your parent) returned to work?

□ Yes (go to question 12)
□ No (go to question 16)

12.) How many days of work did you miss? ______ (go to question 16)
13.) In the time since you visited the doctor for suspected chikungunya, have you been unable to do your normal
chores and activities?
□ Yes (go to question 14)
□ No (go to question 16)
14.) How many days of chores/activities have you missed? ______ (go to question 16)
15.) Have you (or has your parent) had to miss work to care for your sick child (or you)?
□ Yes (go to question 11)
□ No (go to question 16)

16.) Were you been hospitalized due to your illness for which you were tested for chikungunya?
□ Yes (go to question 17)
□ No (go to question 18)
17.) How many days were you hospitalized? ________
18.) Did you seek additional medical attention following the date your sample was drawn for suspected
chikungunya?
□ Yes (go to question 19)
□ No (go to question 20)
19.) How many times did you seek medical attention? ________ healthcare visits

20.) Do you have a history of chronic joint pain prior to being diagnosed with chikungunya?
□ Yes
□ No
Thank you for answering our additional question. The information you have provide will let us learn more about
chikungunya and how the disease is affecting you and other people in your community.
Would you be willing for the health department to contact you again related to your illness?
Finally, do you have any questions for me?

 

□ Yes
□ No

CHIKUNGUNYA INVESTIGATION — HOUSEHOLD INTERVIEW FORM

 Form Approved 
OMB No. 0920‐1011 
Exp. Date 03/31/2017 

 

TEAM #:   
GPS Coordinates:

 
.

DATE: 

/ 
,

_/  

 

.

Household ID (e.g., SJ-1-A):

-

-

SANID of lab-positive case:

How many people live in this house?
people
List all members of household below put yourself first.
Head of household contact number to facilitate return of test results:_
 

Name (First, Paternal, Maternal)
1 

Age

Gender

Participate?

M/F

Yes / No

 

2 

 

3 

 

 
 

M/F

4 
5 
6 

Yes / No
 

M/F

Yes / No

M/F

Yes / No

M/F

Yes / No

M/F

Yes / No

 

 

 

 

 

7 

 

8 

 

Place sticker here

 
 

M/F

Yes / No
 

M/F

Yes / No

Public reporting burden of this collection of information is estimated to average 15 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data 
needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB 
control number. Send comments regarding this burden estimate or any other aspect of this collection of information including suggestions for reducing this burden to CDC/ATSDR Reports Clearance Officer; 1600 Clifton 
Road NE, MS D‐74 Atlanta, Georgia 30333; ATTN: PRA (0920‐1011) 

 

CHIKUNGUNYA INVESTIGATION — HOUSEHOLD INTERVIEW FORM

 

  

Household Characteristics
Housing type (check only one):

□Public housing

□ One story house

□ Two story house □

Apartment/condo building

□ Temporary shelter

Has anyone in your immediate household traveled outside of Puerto Rico in the past 3 months?
Has anyone in your household been sick in the past 3 months?

□ Yes

□ Yes

□ No

Does your home have screened windows and doors?

□ All rooms

Do you regularly use air conditioning in your home?

□ Yes, in all rooms □ Yes, but only in some rooms

Do you regularly leave your doors or windows open?

□ Daytime only

Do you use mosquito coils in your house or patio?

□

Yes

Do you use citronela in your house or patio to keep mosquitoes away?

□ Some rooms

□ No
□ No

□ Night-time only □ Always □ Never

□ No
□

Yes

□ No

Notes:

 

□ No

 

Form Approved 
OMB No. 0920‐1011 
Exp. Date 03/31/2017 
 

Chikungunya Investigation ‐ Individual Interview Form 
Team #:

Interviewer:

Date of interview:

Individual ID (e.g., SJ-1-A-1):

-

-

/_

/_

-

1. Name:
First (given)
2. Gender:

□ Male □Female

Initial

Paternal

Maternal

3. Date of Birth (MM/DD/YYYY):

4. How long have you been living in Puerto Rico?

/

/

years

5. Have you been told by a clinician that you have any of the following medical conditions?

□ Diabetes □ High blood pressure
□ Stroke □ Kidney disease
□ Asthma □ Lung disease

□ Heart disease
□ Liver disease
□ Joint disease/arthritis

□ High cholesterol
□ Thyroid disease
□ Cancer

6. Do you take any of the following medications daily:

□ NSAID (e.g., aspirin, Iburpofen) □ Corticosteroids

□ Antibiotics
□ No
7. Have you experiencing any new illnesses in the past 3 months? □Yes
(If more than one illness episode, detail each additional episode in Notes.)
7a. If yes, first day of illness (MM/DD/YYYY):

/

/

_

7b. What symptoms did you have (check all that apply)?

□ Fever
□ Muscle pain
□ Headache
□ Runny nose

□ Chills
□ Joint pain
□ Pain behind eyes
□ Sore throat

□ Nausea/Vomiting
□ Skin rash
□ Abdominal pain
□ Calf pain

□ Diarrhea
□ Red eyes
□ Cough
□ Arthritis (red, swollen

joints)

□ Minor bleeding (e.g., petechia, gum bleed, nosebleed, severe bruising)
□ Major bleeding (e.g., vomiting blood, coughing up blood, blood in stool, heavy menses)

Public reporting burden of this collection of information is estimated to average 15 minutes per response, including the time for reviewing 
instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of 
information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a 
currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information including 
suggestions for reducing this burden to CDC/ATSDR Reports Clearance Officer; 1600 Clifton Road NE, MS D‐74 Atlanta, Georgia 30333; ATTN: PRA 
(0920‐1011) 

□ 7b-1. If you had joint pain, indicate the locations where you had the pain

7c. How long did this illness last?

days

□ Yes

7d. Did you go to the doctor because of this illness?

□ No

7d-1. If yes, Name of hospital/clinic:
7d-2. What was the diagnosis?

□ Viral syndrome □ I don’t know

□Chikungunya
□ Other:

7d-3. Were you hospitalized for this illness?

□ Dengue

□ Yes □

No

7d-3a. If yes, Hospital Name:
7d-3b. Days in the hospital:

days

8. Have you used mosquito repellent in the past month?
9. Have you slept under a bednet in the past month?

□ Daily

□ Yes

□ Weekly □ Never
□ No

10. Have you traveled outside of Puerto Rico in the past 3 months? □ Yes

□ No

10a. If yes, specify where and date of return to Puerto Rico for the most recent trip:

□ United States (excluding USVI) □ Dominican Republic
□Other:
Date of return to PR (MM/DD/YYYY):
NOTES: 

/

/

□Caribbean cruise

Form Approved
OMB No. 0920-1011

SISTEMA CENTINELA DE VIGILANCIA DE CHIKUNGUNYA (CHIKSS)
REPORTE DE CASO

Exp.: 3/31/2014

REVISADO:

FIEBRE + POLIARTRALGIA + NO TOS

(iniciales)

Fecha de hoy:

/

/
Día Mes Año

SOLAMENTE PARA USO DEL LABORATORIO
Número de caso

Espécimen # Días después 1er síntoma Tipo Fecha recibido Espécimen # Días después 1er síntoma Tipo Fecha recibido
S1

GCODE

SAN ID

S3

S2

S4

Favor de leer y completar TODAS las secciones
Datos del paciente

Se hospitalizó por esta enfermedad:

Sí → Nombre del hospital:

No

Número de expediente:

Nombre del Paciente:
Apellido paterno

Apellido materno

Nombre

Segundo nombre / inicial

Falleció:
Sí

No

No sabe

Cambios en estado mental:

Si el paciente es un menor, nombre del padre o encargado:
Apellido paterno

Nombre

Apellido materno

Dirección residencial completa (Física)

Sí

Segundo nombre / inicial

No

No sabe

Médico o proveedor que ordenó la prueba de chikungunya

Dirección de la casa aquí

Nombre:
Hospital:
Municipio:

Código postal:

Tel.:

-

Otro Tel.:

CDT San José

Bella Vista

HIMA Fajardo

Buen Samaritano

San Jorge Children’s

HIMA Caguas

Susoni

Vive cerca de:
Nombre y dirección del trabajo:

Información demográfica del paciente

Fecha nacimiento:
/
Día

/
Mes

Edad:

meses

ó Edad:

Sexo:

años ¿Encinta?:

Año

¿Quién llenó este formulario?
M

F

Sí

No

Doctor(a)

NS

Enfermero(a)

OTRO

Semanas de gestación

Datos indispensables para procesar las muestras

Datos adicionales del paciente
¿Cuántos años ha vivido en este municipio?

Día

Fecha del primer síntoma:

Mes

/

Año

/

¿En qué país nació?
¿Durante los 14 días antes de enfermar, ¿VIAJÓ a otro país o pueblo?
Sí, otro país

Fecha de toma de muestra:

/

/

Sí, otro pueblo

No

No sabe

¿A dónde viajó?

¿Desde que se enfermó, faltó a la escuela/trabajo?
SI

NO

NO APLICA

POR FAVOR indique todos los signos y síntomas del paciente
Sí

No

No sabe

Fiebre durante 2 – 7 días ........................
Fiebre (>38ºC/101ºF)................................

Señales de advertencia

Presión arterial (SBP/DBP) :

Conteo

Letargia/inquietud….………………....
Agrandamiento del hígado > 2cm…

de plaquetas:

Efusión pleural o abdominal…………

Petequias……………………………….

Síntomas adicionales

Equimosis o Cardenales………….....

Diarrea…………………………………..

Vómito con sangre…………………...
Hemorragia nasal…………………....

Pulso acelerado y débil…………...…….

Conjuntivitis…………………………….

Hemorragia de las encías………….

Palidez o piel fría ………………………....

Sangre en la orina……………………

Congestión nasal……………………..

Erupción de la piel………………………..

(sobre 5 RBC/hpf o positivo para sangre)

CONTINÚE AL DORSO!!

Dolor de cabeza…………………………..
Dolor en los ojos…………………………...
Dolor en el cuerpo ……………………….
Dolor de coyunturas ……………………..
Anorexia…………………………………….

Sí

No

No sabe

Tos…………………………………….....

Sangre en la excreta…………………

Síntomas

Urianálisis positivo……………………

No sabe

Sangrado de las mucosas …………..

Conteo de glóbulos blancos (WBC):

Hemorragia vaginal…………………

No

Dolor abdominal/sensibilidad ……..

/

Hematocrito (%):

Alguna manifestación hemorrágica

Sí

Vómito persistente ......……………. ...

Medidas Clínicas

Dolor de garganta……………………
Ictericia………………………………..
Convulsión o coma………………….
Náusea y vómito (ocasional)…….
Artritis (coyunturas hinchadas)……
No puede caminar ………………….

Este formulario está autorizado por la Ley 42 USC 241 del Servicio de Salud Pública. Contestar este formulario es voluntario, pero, se necesita la cooperación del paciente para el estudio y
control de enfermedades. Contestar las preguntas toma aproximadamente 15 minutos por formulario. Envíe sus comentarios y sugerencias sobre el tiempo que toma llenar el formulario o sobre
cualquier otro aspecto de la recopilación de información a: CDC/ATSDR Reports Clearance Officer; 1600 Clifton Road NE, MS D-74 Atlanta, Georgia 30333; ATTN: PRA (0920-1011).

Los círculos a continuación representan las coyunturas en el cuerpo humano, 
marque con una “X” las áreas donde el paciente tiene DOLOR 
Columna vertebral 

DERECHA 

IZQUIERDA

Los círculos a continuación representan las coyunturas en el cuerpo humano, 
marque con una “X” las áreas donde el paciente tiene LAS COYUNTURAS ROJAS    
E HINCHADAS 
Columna vertebral 

DERECHA 

IZQUIERDA

ESPACIO PARA ETIQUETA 
DEL LABORATORIO 

Form Approved
OMB No. 0920-1011
Exp. Date 03/31/2017

Appendix 1:

VIRAL HEMORHAGIC FEVER
CASE INVESTIGATION FORM

Public reporting burden of this collection of information is estimated to average 25 minutes per response, including the time for
reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing
the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of
information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other
aspect of this collection of information including suggestions for reducing this burden to CDC/ATSDR Reports Clearance Officer;
1600 Clifton Road NE, MS D-74 Atlanta, Georgia 30333; ATTN: PRA (0920-1011)

VIRAL HEMORHAGIC FEVER
CASE INVESTIGATION FORM

Outbreak
Case ID:
Health
Facility
Case ID:

Date of Case Report: ____/____/_____ (D, M, Yr)

Section 1.

Patient Information

Patient’s Surname: ______________________ Other Names:____________________________
Age: _______
Years
Months
Gender:
Male
Female
Phone Number of Patient/Family Member:_____________________ Owner of Phone: ________________
Status of Patient at Time of This Case Report:

Alive

Dead

If dead, Date of Death: ___/___/____ (D, M, Yr)

Permanent Residence:
Head of Household: __________________________ Village/Town: _______________________ Parish: __________________________
Country of Residence: _________________ District: ____________________________ Sub-County: ____________________________
Occupation:
Farmer
Butcher
Hunter/trader of game meat
Miner
Religious leader
Housewife
Pupil/student
Child
Businessman/woman; type of business: _____________________
Transporter; type of transport: ___________________________
Healthcare worker; position: _________________ healthcare facility: ___________________
Traditional/spiritual healer
Other; please specify occupation: _____________________________________________________
Location Where Patient Became Ill:
Village/Town: _________________________ District: _________________________ Sub-County: _________________________
GPS Coordinates at House: latitude: __________________ longitude: ________________________
If different from permanent residence, Dates residing at this location: ___/___/____ - ___/___/____ (D, M, Yr)

Section 2.

Clinical Signs and Symptoms

Date of Initial Symptom Onset:

____/____/______ (D, M, Yr)

Please tick an answer for ALL symptoms indicating if they occurred during this illness between symptom onset and case detection:

Fever
If yes, Temp: ____º C Source:

Yes
Axillary

Vomiting/nausea
Diarrhea
Intense fatigue/general weakness
Anorexia/loss of appetite
Abdominal pain
Chest pain
Muscle pain
Joint pain
Headache
Cough
Difficulty breathing
Difficulty swallowing
Sore throat
Jaundice (yellow eyes/gums/skin)
Conjunctivitis (red eyes)
Skin rash
Hiccups
Pain behind eyes/sensitive to light
Coma/unconscious
Confused or disoriented

Section 3.

Oral

No

Unk

Rectal

Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes

No
No
No
No
No
No
No
No
No
No
No
No
No
No
No
No
No
No
No
No

Unk
Unk
Unk
Unk
Unk
Unk
Unk
Unk
Unk
Unk
Unk
Unk
Unk
Unk
Unk
Unk
Unk
Unk
Unk
Unk

Unexplained bleeding from any site
If Yes:
Bleeding of the gums
Bleeding from injection site
Nose bleed (epistaxis)
Bloody or black stools (melena)
Fresh/red blood in vomit (hematemesis)
Digested blood/“coffee grounds” in vomit
Coughing up blood (hemoptysis)
Bleeding from vagina,
other than menstruation
Bruising of the skin
(petechiae/ecchymosis)
Blood in urine (hematuria)

Yes

No

Unk

Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes

No
No
No
No
No
No
No
No

Unk
Unk
Unk
Unk
Unk
Unk
Unk
Unk

Yes

No

Unk

Yes

No

Unk

Other hemorrhagic symptoms
Yes
No
Unk
If yes, please specify: ___________________________
Other non-hemorrhagic clinical symptoms:
Yes
No
If yes, please specifiy: ___________________________

Unk

Hospitalization Information

At the time of this case report, is the patient hospitalized or currently being admitted to the hospital?
If yes, Date of Hospital Admission: ____/____/_____ (D, M, Yr)

Yes

No

Health Facility Name: ________________________________________

Village/Town: __________________________ District: _______________________ Sub-County: _________________________
Is the patient in isolation or currently being placed there?
Yes
No
If yes, date of isolation: ____/____/_____ (D, M, Yr)
Was the patient hospitalized or did he/she visit a health clinic previously for this illness?

Yes

No

Unk

If yes, please complete a line of information for each previous hospitalization:
Dates of Hospitalization

Health Facility Name

Village

District

Was the patient isolated?

___/___/____ - ___/___/____ (D, M, Yr)

Yes
No

___/___/____ - ___/___/____ (D, M, Yr)

Yes
No

Outbreak
Case ID:

Section 4.

Epidemiological Risk Factors and Exposures

IN THE PAST ONE(1) MONTH PRIOR TO SYMPTOM ONSET:
1. Did the patient have contact with a known or suspect case, or with any sick person before becoming ill?
If yes, please complete one line of information for each sick source case:
Name of Source
Case

Relation to
Patient

Dates of Exposure

Village

District

No

Was the person dead or alive ?

Unk
Contact
Types**

(D, M, Yr)
Alive
Dead, date of death: ___/___/____ (D, M, Y)
Alive
Dead, date of death: ___/___/____ (D, M, Y)
Alive
Dead, date of death: ___/___/____ (D, M, Y)

___/___/___ - ___/___/___
___/___/___ - ___/___/___
___/___/___ - ___/___/___

**Contact Types:
(list all that apply)

Yes

1 – Touched the body fluids of the case (blood, vomit, saliva, urine, feces)
2 – Had direct physical contact with the body of the case (alive or dead)
3 – Touched or shared the linens, clothes, or dishes/eating utensils of the case
4 – Slept, ate, or spent time in the same household or room as the case

2. Did the patient attend a funeral before becoming ill?
Yes
No
Unk
If yes, please complete one line of information for each funeral attended:
Name of Deceased Person Relation to Patient

Dates of Funeral
Attendance (D, M, Yr)

Village

District

Did the patient participate
(carry or touch the body)?

___/___/____ - ___/___/____

Yes

No

___/___/____ - ___/___/____

Yes

No

3. Did the patient travel outside their home or village/town before becoming ill?
Yes
No
Unk
If yes, Village: __________________________ District: ______________________ Date(s): ___/___/____ - ___/___/____
4. Was the patient hospitalized or did he/she go to a clinic or visit anyone in the hospital before this illness?
If yes, Patient Visited: ____________________ Date(s): ___/___/____ - ___/___/____ (D, M, Yr)

Yes

(D, M, Yr)

No

Unk

Health Facility Name: _________________________ Village: _____________________ District: _______________________
5. Did the patient consult a traditional/spiritual healer before becoming ill?

Yes

No

Unk

If yes, Name of Healer: _____________________Village: _______________ District: _____________ Date: ___/___/____ (D, M, Yr)
6. Did the patient have direct contact (hunt, touch, eat) with animals or uncooked meat before becoming ill?
If yes, please tick all that apply:
Animal:
Status (check one only):
Bats or bat feces/urine
Healthy
Sick/Dead
Primates (monkeys)
Healthy
Sick/Dead
Rodents or rodent feces/urine
Healthy
Sick/Dead
Pigs
Healthy
Sick/Dead
Chickens or wild birds
Healthy
Sick/Dead
Cows, goats, or sheep
Healthy
Sick/Dead
Other; specify______________
Healthy
Sick/Dead
7. Did the patient get bitten by a tick in the past 2 weeks?

Section 5.

Yes

No

Yes

No

Unk

Unk

Clinical Specimens and Laboratory Testing

Specimen/shipping instructions:  Label sample with patient name, date of collection, and case ID

 Send sample cold with a cold/ice pack, and packaged appropriately.
 Collect whole blood in a purple top (EDTA) tube – green or red top tubes
acceptable if purple not available
 Preferred sample volume = 4ml (minimum sample volume = 2ml)

Has this patient had a sample submitted previously?
Sample 1:

Yes

Do not complete
UVRI Only

Sample 2:

Sample Collection Date: ____/____/______

(D, M, Yr)

Sample Type:
Whole Blood
Post-mortem heart blood
Skin biopsy
Other specimen type, specify: ________________

Section 6.

No
Do not complete
UVRI Only

Sample Collection Date: ____/____/______ (D, M, Yr)
Sample Type:
Whole Blood
Post-mortem heart blood
Skin biopsy
Other specimen type, specify: ________________

Case Report Form Completed by:

Name: ______________________________ Phone: _________________________ E-mail: _______________________________
Position: _____________________________ District: _____________________ Health Facility: ____________________________
Information provided by:
Patient
Proxy; If proxy, Name:______________________ Relation to Patient: ___________________

Outbreak
Case ID:

Case
Name:

**If the patient is deceased or has already recovered from illness, please fill out the next section.
**If the patient is currently admitted to the hospital, leave the next section blank (it will be completed upon discharge)

Section 7.

Patient Outcome Information

Please fill out this section at the time of patient recovery and discharge from the hospital OR at the time of patient death.
Date Outcome Information Completed: ____/____/_____ (D, M, Yr)
Final Status of the Patient:

Alive

Dead

Did the patient have signs of unexplained bleeding at any time during their illness?
Yes
No
Unk
If yes, please specify: _______________________________________________________________________________
If the patient has recovered and been discharged from the hospital:
Name of hospital discharged from: _______________________________ District: _________________________________
If the patient was isolated, Date of discharge from the isolation ward: ____/____/______ (D, M, Yr)
Date of discharge from the hospital: ____/____/______

(D, M, Yr)

If the patient is dead:
Date of Death: ____/____/______ (D, M, Yr)
Place of Death:
Community
Hospital: _______________________
Other: ________________________________
Village: _______________________ District: _________________________ Sub-County: _______________________
Date of Funeral/Burial: ____/____/______ (D, M, Yr)
Funeral conducted by:
Family/community
Outbreak burial team
Place of Funeral/Burial:
Village: _______________________ District: _________________________ Sub-County: _______________________
Please tick an answer for ALL symptoms indicating if they occurred at any time during this illness including during hospitalization:

Fever
If yes, Temp: ____º C Source:

Yes
Axillary

Vomiting/nausea
Diarrhea
Intense fatigue/general weakness
Anorexia/loss of appetite
Abdominal pain
Chest pain
Muscle pain
Joint pain
Headache
Cough
Difficulty breathing
Difficulty swallowing
Sore throat
Jaundice (yellow eyes/gums/skin)
Conjunctivitis (red eyes)
Skin rash
Hiccups
Pain behind eyes/sensitive to light
Coma/unconscious
Confused or disoriented

Oral

No

Unk

Rectal

Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes

No
No
No
No
No
No
No
No
No
No
No
No
No
No
No
No
No
No
No
No

Unk
Unk
Unk
Unk
Unk
Unk
Unk
Unk
Unk
Unk
Unk
Unk
Unk
Unk
Unk
Unk
Unk
Unk
Unk
Unk

Other non-hemorrhagic clinical symptoms:
Yes
No
If yes, please specifiy: ____________________________

Unk

Form Approved
OMB No. 0920-1011
Exp. Date 03/31/2017

Appendix 2:

CONTACT TRACING FORM

Public reporting burden of this collection of information is estimated to average 3 minutes per response, including the time for
reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing
the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of
information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other
aspect of this collection of information including suggestions for reducing this burden to CDC/ATSDR Reports Clearance Officer;
1600 Clifton Road NE, MS D-74 Atlanta, Georgia 30333; ATTN: PRA (0920-1011)

*8,1($ VIRAL HEMORRHAGIC FEVER CONTACT LISTING FORM
Case Information
UVRI/MoH
Case ID

Surname

Other Names

Head of Household

Village

Sub-County

District

Date of
Symptom
Onset

Date of
Admission to
Isolation

Date of Death

**For all information on location, please list information on where the contact will be residing for the next month.

Contact Information
Surname

Other
Names

Sex Age Relation
(M/F) (yrs) to Case

Date of
Last
Contact
with Case

Type of
Contact
(1,2,3,4)*
list all

Head of
Household

Village

District

SubCounty

LC1
Chairman

Phone Number

Healthcare
Worker (Y/N)
If yes, what
facility?

*Types of Contact:
1 = Touched the body fluids of the case (blood, vomit, saliva, urine, feces)
2 = Had direct physical contact with the body of the case (alive or dead)
3 = Touched or shared the linens, clothes, or dishes/eating utensils of the case
4 = Slept, ate, or spent time in the same household or room as the case

Contact Sheet Filled by:

Name: ___________________________________ Position: ___________________________ Phone: ________________________

UAC Respiratory Disease Cluster
Case Investigation Form

Form Approved
OMB No. 0920-1011
Exp. Date 03/31/2017

State: _____ Date reported to health department: ___/___/_____ (MM/DD/YYYY) Date interview completed: ___/___/_____ (MM/DD/YYYY)
Alien Number:_______________________________________________ CDC Lab ID: ________________________________________________
Demographic Information
1. Date of birth: _____/_____/_____ (MM/DD/YYYY)
2. Country of origin: ____________________________ Region: ____________________________ City/town: ___________________________
3. Estimated travel time from country of origin to US border: ___________ days weeks months
4. Ethnicity:
Hispanic or Latino
Not Hispanic or Latino
5. Sex:
Male
Female
Symptoms and Care Seeking
6. What date did symptoms associated with this illness start? _____/_____/_______ (MM/DD/YYYY)
7. Were symptoms present at the CBP Processing Center?
Yes
No
Unknown
8. Were symptoms present at a CBP facility before transfer to the processing center?
Yes, which facility? _______________ No Unknown
9. During this illness, did the patient experience any of the following?
Symptom
Symptom Present?
Symptom
Symptom Present?
Fever (highest temp _________ oF)
Yes
No
Unk Shortness of breath
Yes
No
Unk
If fever present, date of onset ___/___/____ (MM/DD/YYYY)
Vomiting
Yes
No
Unk
Felt feverish
Yes
No
Unk Diarrhea
Yes
No
Unk
If felt feverish, date of onset ___/___/____ (MM/DD/YYYY)
Eye infection/redness
Yes
No
Unk
Cough
Yes
No
Unk Rash
Yes
No
Unk
Sore Throat
Yes
No
Unk Fatigue
Yes
No
Unk
Muscle aches
Yes
No
Unk Seizures
Yes
No
Unk
Headache
Yes
No
Unk Back pain
Yes
No
Unk
Abdominal pain
Yes
No
Unk Other, specify
Yes
No
Unk
10. Does the patient still have symptoms?
Yes (skip to Q.12)
No
Unknown (skip to Q.12)
11. When did the patient feel back to normal? _____/_____/_____ (MM/DD/YYYY)
12. Did the patient receive any medical care for the illness?
Yes
No (skip to Q.14)
Unknown (skip to Q.14)
13. Where and on what date did the patient seek care (check all that apply)?
CBP Processing Center date:_____/_____/_____ (MM/DD/YYYY)
Shelter medical service date:_____/_____/_____ (MM/DD/YYYY)
Urgent care date:_____/_____/_____ (MM/DD/YYYY)
Emergency room date:_____/_____/_____ (MM/DD/YYYY)
Other _______________________________ date:_____/_____/_____ (MM/DD/YYYY)
Unknown
14. Did the patient experience any other complications as a result of this illness?
Yes (please describe below)
No
Unknown
____________________________________________________________________________________________________________________
15. Does the patient have any preexisting medical conditions (e.g. problems with heart, lung)?
Yes (please describe below)
No
Unknown
____________________________________________________________________________________________________________________
Risk Factors
16. In the 7 days prior to illness onset, please list the locations/CPB facilities the patient has been (including international).
Location 1: Dates: _____/_____/_____ to _____/_____/_____ Country _____________ State ______ City/CPB facility__________________
Location 2: Dates: _____/_____/_____ to _____/_____/_____ Country _____________ State ______ City/CPB facility__________________
Location 3: Dates: _____/_____/_____ to _____/_____/_____ Country _____________ State ______ City/CPB facility__________________
17. Which dormitory was the patient in when symptomatic? ________ (dormitory 101-110)
18. Which bed number was the patient in when symptomatic? ___________
19. Does the patient know anyone who had fever, respiratory symptoms like cough or sore throat, or another respiratory illness like pneumonia in
the 7 days BEFORE the case patient’s illness onset?
Yes (please list those ill before the case patient in the table below)
No
Unknown
Sex
Date of
Contact name
Age
Comments
(M/F)
illness onset

Public reporting burden of this collection of information is estimated to average 30 minutes per response, including the time for reviewing instructions, searching
existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor,
and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden
estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC/ATSDR Information Collection Review Office,
1600 Clifton Road NE, MS D-74, Atlanta, Georgia 30333; ATTN: PRA (0920-1011.

UAC Respiratory Disease Cluster
Case Investigation Form
20. Any additional comments or notes?
____________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________
Please review the patient’s medical record, patient testing results, and facility records to obtain the answers for the remainder of the form.
Clinical Course, Treatment, and Outcome
21. Date of identification by CBP: _____/_____/_____ (MM/DD/YYYY)
22. Date of arrival to CBP Processing Center: _____/_____/_____ (MM/DD/YYYY)
Nogales, AZ or
McAllen, TX
Other: ____________
23. Date of arrival to Baytown Shelter: _____/_____/_____ (MM/DD/YYYY)
24. Approximately how many children were in the patient’s dormitory at the shelter on the date of symptom onset? ______________
25. Were other persons in the same dormitory symptomatic in the 7 days prior to the illness onset in this patient?
Yes
No (skip to Q.27)
Unknown (skip to Q.27)
26. How many persons were ill? ____________________
27. Was the patient hospitalized for the illness?
Yes
No (skip to Q.36)
Unknown (skip to Q.36)
28. Date(s) of hospital admission? First admission date:___/___/____ (MM/DD/YYYY) Second admission date:___/___/____ (MM/DD/YYYY)
29. Was the patient admitted to an intensive care unit (ICU)?
Yes
No (skip to Q.31)
Unknown (skip to Q.31)
30. Date of ICU admission: ______/_____/_______ (MM/DD/YYYY) Date of ICU discharge: ______/_____/_______ (MM/DD/YYYY)
31. Did the patient receive mechanical ventilation / have a breathing tube?
Yes
No (skip to Q.33)
Unknown (skip to Q.33)
32. For how many days did the patient receive mechanical ventilation or have a breathing tube? ___________________ days
33. Was the patient discharged?
Yes
No (skip to Q.36)
Unknown (skip to Q.36)
34. Date(s) of hospital discharge? First discharge date:___/___/____ (MM/DD/YYYY) Second discharge date:___/___/____ (MM/DD/YYYY)
35. Where was the patient discharged?
NBVC Shelter
Family member
Permanent shelter
Other _________________________
Unknown
36. Did the patient have a new abnormality on chest x-ray or CAT scan?
No, x-ray or scan was normal
Yes, x-ray or scan detected new abnormality
No, chest x-ray or CAT scan not performed
Unknown
37. Did the patient receive a diagnosis of pneumonia?
Yes
No
Unknown
38. Did the patient receive a diagnosis of ARDS?
Yes
No
Unknown
39. Did the patient receive antimicrobials prior to becoming ill (within 2 weeks) or after becoming ill?
Yes, (please complete table below)
No
Unknown
Start date
End date
Total number of days
Dosage
Drug
(MM/DD/YYYY) (MM/DD/YYYY)
receiving antivirals
(if known)
Oseltamivir (Tamiflu)
mg
Zanamivir (Relenza)
mg
Azithromycin
mg
Levofloxacin
mg
Augmentin
mg
Penicillin
mg
Other antimicrobial_____________________
mg
Other antimicrobial_____________________
mg
Other antimicrobial_____________________
mg
40. Did the patient die as a result of this illness?
Yes, Date of death:_____/_____/_____ (MM/DD/YYYY)
No
Unknown

Appendix A: Case Investigation Form

2

UAC Respiratory Disease Cluster
Case Investigation Form
Medical History -- Past Medical History and Vaccination Status
41. Were any of the following chronic medical conditions noted during patient interview or recorded on the patient’s medical record? Please specify
ALL conditions noted.

42.
43.
44.
45.
46.
47.
48.

a.

Asthma/reactive airway disease

Yes

No

Unknown

b.

Tuberculosis

Yes

No

Unknown (If YES, specify) _______________________________

c.

Other chronic lung disease

Yes

No

Unknown (If YES, specify) _______________________________

d.

Chronic heart or circulatory disease

Yes

No

Unknown (If YES, specify) _______________________________

e.

Diabetes mellitus

Yes

No

Unknown (If YES, specify) _______________________________

f.

Kidney or renal disease

Yes

No

Unknown (If YES, specify) _______________________________

g.

Non-cancer immunosuppressive condition

Yes

No

Unknown (If YES, specify) _______________________________

h.

Cancer chemotherapy in past 12 months

Yes

No

Unknown (If YES, specify) _______________________________

i.

Neurologic/neurodevelopmental disorder

Yes

No

Unknown (If YES, specify) _______________________________

j.

Cerebrospinal fluid leaks

Yes

No

Unknown (If YES, specify) _______________________________

k.

Chronic liver disease

Yes

No

Unknown (If YES, specify) _______________________________

l.

Sickle cell/other hemaglobinopathies

Yes

No

Unknown (If YES, specify) _______________________________

m. Congenital or acquired asplenia

Yes

No

Unknown (If YES, specify) _______________________________

n.

Yes

No

Unknown (If YES, specify weight/height) ___________________

Malnutrition

o. Other chronic diseases
Yes
No
Unknown (If YES, specify) _______________________________
Was patient pregnant or ≤6 weeks postpartum at illness onset?
Yes, pregnant (weeks pregnant at onset)________
Yes, postpartum (delivery date) ___/___/____ (MM/DD/YYYY)
No
Unknown
Does the patient currently smoke?
Yes
No
Unknown
Was the patient vaccinated against influenza in the past year?
Yes
No (skip to Q.47)
Unknown (skip to Q.47)
Month and year of influenza vaccination? Vaccination date 1:____/_____ (MM/YYYY) Vaccination date 2:____/_____ (MM/YYYY)
Type of influenza vaccine (check all that apply):
Inactivated (injection)
Live attenuated (nasal spray)
Unknown
Did the patient ever receive the pneumococcal vaccine?
Yes
No (skip to Q.49)
Unknown (skip to Q.49)
Month and year of pneumococcal vaccination? Vaccination date 1:____/_____ (MM/YYYY)

Specimen Testing Results
49. Was the patient tested for any pathogens?

 Yes (please complete table below)

 No

 Unknown

Positive Negative Not Tested/Unknown
Collection Date
CT Value
a. Influenza
____/____/______
___________________________



If influenza positive, specify subtype  H1N1pdm09  H3N2  A,subtype unknown  Influenza B  Other___________________  Unknown
b. Pneumococcus
____/____/______
___________________________



c. Respiratory syncytial virus/RSV
____/____/______
___________________________



d. Adenovirus
____/____/______
___________________________



e. Parainfluenza 1



____/____/______
___________________________
f. Parainfluenza 2



____/____/______
___________________________
g. Parainfluenza 3



____/____/______
___________________________
h. Human metapneumovirus



____/____/______
___________________________
i. Rhinovirus



____/____/______
___________________________
j. Coronavirus



____/____/______
___________________________
k. Other, specify: _________________
____/____/______
___________________________



l. Other, specify: __________________
____/____/______
___________________________



m. Other, specify: _________________
____/____/______
___________________________




Appendix A: Case Investigation Form

3

UAC Respiratory Disease Cluster
Case Investigation Form

Form Approved
OMB No. 0920-1011
Exp. Date 03/31/2017

Estado: _TX_ Fecha de reporte al Departamento de Salud: ___/___/___ (MM/DD/AAAA) Fecha de la entrevista: ___/___/_____ (MM/DD/AAAA)
Número de extranjería:_______________________________________________ CDC Lab ID: __________________________________________
Información Demográfica
1. Fecha de nacimiento: _____/_____/_____ (MM/DD/AAAA)
2. País de origen: ___________________Region:____________________Ciudad/Pueblo:_______________________________________
3. Tiempo de viaje estimado de país de origen a la frontera con EEUU: ________ días semanas meses
4. Etnia:
Hispano ó Latino
No Hispano ó Latino
5. Sexo:
Masculino
Femenino
Síntomas, Curso Clínico de la enfermedad, Tratamiento, Análisis de las muestras y Resultados
6. En qué fecha comenzaron los síntomas asociados con la enfermedad? _____/_____/_______ (MM/DD/AAAA) (VER CALENDARIO)
7. Los síntomas estaban presentes al llegar a la Base de la Patrulla de Frontera de los EEUU?
Si
No
No sabe
8. Los síntomas estaban presentes antes de llegar a la Base de la Patrulla de Frontera de los EEUU?
Si
No
No sabe, si dijo si
Cual?___________
9. Durante el curso de la enfermedad, el paciente manifestó alguno de los siguientes síntomas?
Síntoma
Presentó?
Síntoma
Presentó?
Fiebre (Temperatura más alta __ oF)
Si
No
No sabe Dificultad para respirar
Si
No
No sabe
Si presentó fiebre, fecha de inicio __/__/___(MM/DD/AAAA)
Vómitos
Si
No
No sabe
Se sintió afiebrado
Si
No
No sabe Diarrea
Si
No
No sabe
Si se sintió afiebrado, fecha de inicio__/__/__(MM/DD/AAAA) Infección en los ojos/Ojos rojos
Si
No
No sabe
Tos
Si
No
No sabe Salpullido
Si
No
No sabe
Dolor de garganta
Si
No
No sabe Fatiga
Si
No
No sabe
Dolor muscular ó de cuerpo
Si
No
No sabe Convulsiones
Si
No
No sabe
Dolor de cabeza
Si
No
No sabe Dolor de espalda
Si
No
No sabe
Dolor abdominal
Si
No
No sabe Otro, especificar
Si
No
No sabe
10. El paciente todavía tiene síntomas?
Si (Pasar a la pregunta Q.12)
No
No sabe (Pasar a la pregunta Q.12)
11. En qué fecha es que el paciente se siente sano nuevamente? _____/_____/_____ (MM/DD/AAAA)
12. Recibió el paciente la atención médica adecuada para tratar la enfermedad?
Si
No (Pasar a la pregunta Q.14)
No sabe (Pasar a la pregunta Q.14)
13. Dónde y en qué fecha es que el paciente solicita atención médica (marcar todas las que apliquen)?
Base de la Patrulla de Frontera de los EEUU fecha:_____/_____/_____ (MM/DD/AAAA)
Clínica de CASA HOGAR fecha:_____/_____/_____ (MM/DD/AAAA)
Clínica de urgencia fecha:_____/_____/_____ (MM/DD/AAAA)
Sala de emergencia fecha:_____/_____/_____ (MM/DD/AAAA)
Otro, especificar _______________________________ fecha:_____/_____/_____ (MM/DD/AAAA)
No sabe
14. El paciente desarrolló alguna complicación como resultado de la enfermedad?
Si (por favor describir/especificar)
No
No
sabe
____________________________________________________________________________________________________________________
15. El paciente tenía alguna condición médica preexistente (por ejemplo condición crónica pulmonar)
Si (por favor describir/especificar)
No
No sabe
____________________________________________________________________________________________________________________
Factores de Riesgo
16. En los 7 días previos al inicio de síntomas, liste la ubicación del paciente (incluyendo zona internacional)
Ubicación 1: Fecha: De_____/____/_____a _____/_____/____ País ____________Estado ______Ciudad/Base Patrulla Fronteriza_________
Ubicación 2: Fecha: De_____/____/____ a _____/_____/____ País ___________ Estado ______ Ciudad/Base Patrulla Fronteriza_________
Ubicación 3: Fecha: De_____/____/____ a _____/_____/____ País ____________ Estado ______ Ciudad/Base Patrulla Fronteriza_________
Ubicación 4: Fecha: De_____/____/_____a _____/_____/____ País ____________Estado ______ Ciudad/Base Patrulla Fronteriza_________
17. En qué numero de dormitorio se encontraba el paciente cuando tuvo los síntomas? ________ (dormitorio 101-110)
18. En qué numero de cama se encontraba el paciente cuando tuvo los síntomas? ___________

Appendix A: Case Investigation Form

4

UAC Respiratory Disease Cluster
Case Investigation Form
19. El paciente conoció a alguien que tuvo fiebre, síntomas respiratorio como tos o dolor de garganta u otro síntoma respiratorio como
neumonía 7 días ANTES del inicio de síntomas en el paciente?
Si (liste todos los que estuvieron enfermos antes que el paciente)
No
No sabe
Fecha de
Sexo
Nombre
Edad
inicio de
Comentarios
(M/F)
síntomas

20. Algún comentario o nota adicional?
____________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________

Appendix A: Case Investigation Form

5

Form Approved 
OMB No. 0920‐1011 
Exp. Date 03/31/17 
 
 
 
 
 
 
 
 
 
 
 
 

 

Hospitalized Case Investigation Form
Respiratory Illness

Public reporting burden of this collection of information is estimated to average 30 minutes per response, including the time for reviewing instructions, searching
existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor,
and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden
estimate or any other aspect of this collection of information including suggestions for reducing this burden to CDC/ATSDR Reports Clearance Officer; 1600 Clifton
Road NE, MS D-74 Atlanta, Georgia 30333; ATTN: PRA (0920-1011)

 

UAC Respiratory Disease Cluster
Hospitalization Case Investigation Form
Alien Number

I. Reporter Information
State/Territory
State/Territory Epi Case ID
State/Territory Lab ID
Date form completed:
/
/
CDC Case ID
Person completing form: First Name:_
Last Name:_
Phone:
What are the source(s) of data for this

Medical chart

Death certificate

Case report form
report? (check all that apply)

Email:_

Other_

II. Patient Information and Medical Care
1. Patient Date of birth:
/
/_
(mm/dd/yyyy)
2. Did the patient have an outpatient or ER

Yes, date:
/_
/
medical care encounter during this illness?
(if multiple, list most recent)
3. Was the patient admitted to the hospital for this 
Yes, date:
/_
/
illness?
Time:
:

AM 
PM
4. Was patient hospitalized previously at another facility during this illness?
Admission date:

/

/_

Discharge date:

/_

/

6. Height

8. Blood Pressure
11. O Sat
2


Inches

/_
%

9. Respiratory Rate


No


Unknown


Yes

Date taken:


Height

per min

12. Fraction of inspired oxygen


Unknown


No


Unknown

Was discharge from prior hospital a transfer?

Please note initial vital signs at hospital admission/ER presentation.
5. Body Mass


No

/_

/_


Yes

(mm/dd/yyyy)

7. Weight:


Lbs.


Weight Unknown

10. Heart Rate
beats/min Temperature:
13. Using: 
O2 mask 
room air 
ventilator


% 
L

°C °F

Specify O2 mask type:

III. Illness Signs and Symptoms
14. Please mark all signs and symptoms experienced or listed in the admission note.
Date of initial symptom onset:
/
/
 Fever (measured) highest temp.
°C °F
Date of fever onset
/_
/_
(mm/dd/yyyy)
 Feverishness (temperature not measured)

Wheezing

Altered mental status
 Cough

Chills

Red or draining eyes (conjunctivitis)
 With sputum (i.e., productive)

Headache

Abdominal pain
 Hemoptysis or bloody sputum

Excessive crying/fussiness (< 5 years old)

Vomiting
 Sore throat

Fatigue/weakness

Diarrhea
 Runny nose (rhinorrhea)

Muscle pain/myalgia

Rash, location
 Dyspnea/difficulty breathing
Location

Other_
 Chest pain

Seizure

IV. Patient Medical History
15. Does the patient have any of the following pre-existing medical conditions? Check all that apply.

15a. 
Asthma/Reactive Airway Disease

  15h. 
Immunocompromising Condition

15b. 
Chronic Lung Disease
 Emphysema/COPD
 Other:_

 HIV infection
 AIDS or CD4 count < 200
 Stem cell transplant (e.g., bone marrow transplant)
 Organ transplant
 Cancer diagnosis within last 12 months (excluding non-

15c. 
Chronic Metabolic Disease
 Diabetes
Insulin dependent 
Yes 
No 
Unknown
 Other:_

 Chemotherapy within last 12 months
 Primary immune deficiency
 Chronic steroid therapy (within 2 weeks of admission)
 Other:

melanoma skin cancer) Type:_

15d. 
Blood disorders/Hemoglobinopathy
 Sickle cell disease
 Splenectomy/Asplenia
 Other:_

 

 
  15i. 
Renal Disease

 Chronic kidney disease/chronic renal insufficiency
 End stage renal disease
 Dialysis
 Nephrotic syndrome
 Other:_

2


No

 

UAC Respiratory Disease Cluster
Hospitalization Case Investigation Form
Alien Number
15e. 
Cardiovascular Disease (excluding hypertension)
 Atherosclerotic cardiovascular disease
 Cerebral vascular incident/Stroke
Yes 
No 
Unknown
With disability 
 Congenital heart disease
 Coronary artery disease (CAD)
 Heart failure/Congestive heart failure
 Other:_
Neuromuscular or Neurologic disorder
15f. 
 Muscular dystrophy
 Multiple sclerosis
 Mitochondrial disorder
 Myasthenia gravis
 Cerebral palsy
 Dementia
 Severe developmental delay
 Plegias/Paralysis
 Epilepsy/Seizure disorder
 Other:_
15g. 
History of Guillain-Barré Syndrome

15j. 
Other

Liver disease

Scoliosis

Obese or BMI ≥ 30

Morbidly obese or BMI ≥ 40

Down syndrome

Pregnant, gestational age in weeks:

Post-partum (≤ 6 weeks)
 Current smoker

Drug abuse

Alcohol abuse

Other:_

PEDIATRIC CASES ONLY (<18 years old)
Abnormality of upper airway

Yes

No
History of febrile seizures

Yes

No
Premature

Yes

No
(gestational age < 37 weeks at birth for patients < 2yrs)
If yes, specify gestation age at birth in weeks:

Unknown gestational age at birth


Unknown


Unknown

Unknown

Unknown

V. Hematology and Serum Chemistries
16. Were any hematology or serum chemistries performed at hospital

Yes

No (skip to Q. 35) 
Unknown (skip to Q. 35)
admission/presentation to care?
Please note initial values at admission/presentation to care. Date values were taken:
/_
/_
(mm/dd/yyyy)
17. White blood cell count (WBC)
cells/mm3 19. Hematocrit (Hct)
% 24. Serum creatinine
mg/dL
18. Differential: Neutrophils
% 20. Platelets (Plt)
103/mm3 25. Serum glucose
mg/dL
Bands
% 21. Sodium (Na)
U/L 26. SGPT/ALT
U/L
Lymphocytes
% 21. Potassium (K)
U/L 27. SGOT/AST
U/L
Eosinophils
% 22. Bicarbonate (HCO3)
mg/dL
U/L 28. Total bilirubin
23. Serum albumin
g/dL 29. C-reactive protein (CRP)
mg/dL
Please describe other significant lab findings (e.g., CSF, protein).
Type of test
Specimen type
Date (mm/dd/yyyy)
Result
31.
/
/
32.
/
/
33.
/
/
34.
/
/

VI. Bacterial Pathogens – Sterile or respiratory site only
35. Was a pneumococcal urinary antigen test performed?

Yes

No

Unknown
If yes, result:

Positive

Negative

Unknown
35. Was a Legionella urinary antigen test performed?

Yes

No

Unknown
If yes, result:

Positive

Negative

Unknown
35. Were any bacterial culture tests performed (regardless of result)? 
Yes

No (skip to Q.41)

Unknown (skip to Q.41)
36. . Indicate sites from which specimens

Blood

Cerebrospinal fluid (CSF)

Bronchoalveolar lavage (BAL)
were collected (check all that apply):

Sputum

Pleural fluid

Endotracheal aspirate 
Other:_
37. Was there culture confirmation of any bacterial infection?

Yes

No (skip to Q.41)

Unknown (skip to Q.41)
38b. Specimen type: 
Blood 
Cerebrospinal fluid (CSF) 
Bronchoalveolar lavage (BAL)
 Sputum
 Pleural fluid
 Endotracheal aspirate
 Other:_
38c. Pathogen(s) identified:
 S. aureus
 S. pyogenes
 S. pneumoniae
 H. influenzae
 Other:
38d. If Staphylococcus aureus, specify:

Methicillin resistant (MRSA)

Methicillin sensitive (MSSA)

Sensitivity unknown
38a. Positive Culture 1 collection date:
/
/
(mm/dd/yyyy)

39b. Specimen type: 
Blood 
Cerebrospinal fluid (CSF) 
Bronchoalveolar lavage (BAL)
 Sputum
 Pleural fluid
 Endotracheal aspirate
 Other:
39c. Pathogen(s) identified:
 S. aureus
 S. pyogenes
 S. pneumoniae
 H. influenzae
 Other:_
39d. If Staphylococcus aureus, specify:

Methicillin resistant (MRSA)

Methicillin sensitive (MSSA)

Sensitivity unknown
39a. Positive Culture 2 collection date:
/
/
(mm/dd/yyyy)

 

3

 

UAC Respiratory Disease Cluster
Hospitalization Case Investigation Form
Alien Number
40b. Specimen type: 
Blood 
Cerebrospinal fluid (CSF) 
Bronchoalveolar lavage (BAL)
 Sputum
 Pleural fluid
 Endotracheal aspirate
 Other:_
40c. Pathogen(s) identified:
 S. aureus
 S. pyogenes
 S. pneumoniae
 H. influenzae
Other:_
40d. If Staphylococcus aureus, specify:

Methicillin resistant (MRSA)

Methicillin sensitive (MSSA)

Sensitivity unknown
40a. Positive Culture 3 collection date:
/
/
(mm/dd/yyyy)

VII. Respiratory Viral Pathogens
41. Was the patient tested for any other viral pathogens? 
Yes
a. Respiratory syncytial virus/RSV
b. Adenovirus
c. Parainfluenza 1
d. Parainfluenza 2
e. Parainfluenza 3
f. Human metapneumovirus
g. Rhinovirus
h. Coronavirus
i. Other, specify:
j. Other, specify:

Positive











Negative












No (skip to Q.42)

Not Tested/Unknown












Unknown (skip to Q.42)
Collection Date
/
/
/
/
/
/
/
/
/
/
/
/
/
/
/
/
/
/
/
/

Specimen Type

VIII. Medications
42. Did the patient receive influenza antiviral medications during illness?

Yes

No

Unknown
Date started
Date stopped
Frequency
Dose
Oseltamivir (Tamiflu)

PO 
IV 
Inhaled
/
/
/
/

QD 
BID 
TID
Zanamivir (Relenza)

PO 
IV 
Inhaled
/
/
/
/

QD 
BID 
TID
Peramivir

PO 
IV 
Inhaled
/
/
/
/

QD 
BID 
TID
Other influenza antiviral:_

PO 
IV 
Inhaled
/
/
/
/

QD 
BID 
TID
Other influenza antiviral:_

PO 
IV 
Inhaled
/
/
/
/

QD 
BID 
TID
43. Did the patient receive antibiotics during the illness?

Yes

No

Unknown
If yes, name
Date started
Date stopped
Dose
/
/
/
/

PO 
IV 
IM
/
/
/
/

PO 
IV 
IM
/
/
/
/

PO 
IV 
IM
/
/
/
/

PO 
IV 
IM
/
/
/
/

PO 
IV 
IM
44. Did the patient receive steroids (excluding inhaled steroids or one time injections) or other

Yes

No

Unknown
immune modulating treatment specifically for this illness?
If yes, name
Date started
Date stopped
Dose
/
/
/
/

PO 
IV 
IM
/
/
/
/

PO 
IV 
IM
/
/
/
/

PO 
IV 
IM
45. Additional treatment comments:

 
 
 

IX. Chest Radiograph – Based on final impression/conclusion of the radiology report
Please include a copy of the radiology report with the form.
46. Did the patient have a chest x-ray within 3 days of
 No (skip to Q.52)

Yes, date
/_
/_
admission?
 No (skip to Q.52)

Yes, date
/_
/_
47. If yes, was the chest x-ray abnormal?
48. For the abnormal chest x-ray, please transcribe the final impression/conclusion and check all that apply:
Final impression/conclusion:

 
 
 
 

4

 Unknown (skip to Q.52)
 Unknown (skip to Q.52)

 

UAC Respiratory Disease Cluster
Hospitalization Case Investigation Form
Alien Number
 
 Single lobar infiltrate
 Multi-lobar infiltrate (unilateral)
 Multi-lobar infiltrate (bilateral)

Lobar
or
segmental
collapse

Cavitation/Abscess/Necrosis
 Round pneumonia
 

Alveolar
(air
space)
disease

Interstitial
disease

Mixed (airspace and interstitial) disease
 Other Infiltrate: 
 Bilateral
 Pleural Effusion:   Unilateral
 Complicated
 Uncomplicated
 Bronchiolitis: 
 Air leak/Pneumothorax
 Lymphadenopathy
 Chest wall invasion
 Other: 

Specify:_
 
49. Did the patient have another chest x-ray within 3

Yes, date
/_
/_

No (skip to Q.52) 
Unknown (skip to Q.52)
days of admission?
50. If yes, was the chest x-ray abnormal?

Yes, date
/_
/_

No (skip to Q.52) 
Unknown (skip to Q.52)
51. For the abnormal chest x-ray, please transcribe the final impression/conclusion and check all that apply:
 Consolidation: 

Final impression/conclusion:

 
 
 
 
 Single lobar infiltrate
 Lobar or segmental collapse
 Other Infiltrate:   Alveolar (air space) disease
 Pleural Effusion:   Unilateral
 Complicated
 Bronchiolitis: 
 Air leak/Pneumothorax
 Other: 
 Specify:_
 Consolidation: 

 

 

 Multi-lobar infiltrate (unilateral)
 Cavitation/Abscess/Necrosis
 Interstitial disease
 Bilateral
 Uncomplicated
 Lymphadenopathy

 Multi-lobar infiltrate (bilateral)
 Round pneumonia
 Mixed (airspace and interstitial) disease

 Chest wall invasion

X. Chest CT or MRI – Based on final impression/conclusion of the radiology report
please include a copy of the radiology report with the form.
52. Did the patient have a chest CT/MRI scan within

Yes, date
/_
/_

No (skip to Q.56) 
Unknown (skip to Q.56)
3 days of admission?
52. If yes, please select one:

CT: contrast

CT: non-contrast

MRI
54. If yes, was the CT/MRI abnormal?

Yes, date
/_
/_

No (skip to Q.56) 
Unknown (skip to Q.56)
55. For abnormal chest CT/ MRI, please check all that apply and please transcribe the final impression/conclusion:
Final impression/conclusion:

 
 
 
 
 Single lobar infiltrate
 Lobar or segmental collapse
 Other Infiltrate:   Alveolar (air space) disease
 Pleural Effusion:   Unilateral
 Complicated
 Bronchiolitis: 

Air leak/Pneumothorax
 Other: 
 Specify:_
 Consolidation: 

 

 

 Multi-lobar infiltrate (unilateral)
 Cavitation/Abscess/Necrosis
 Interstitial disease
 Bilateral
 Uncomplicated
 Lymphadenopathy

 Multi-lobar infiltrate (bilateral)
 Round pneumonia
 Mixed (airspace and interstitial) disease

 Chest wall invasion

XI. Clinical Course and Severity of Illness
56. At any time during the current illness, did the patient require or have the diagnosis of :
a. Admission to intensive care unit (ICU)

Yes
Admission date:
/
/
Discharge date:
If multiple admissions, 2nd ICU admission date:
/
/
2nd ICU discharge date:
If more than 2 ICU admissions, please provide dates in the comments section (Q.66)
 Yes
b. Supplemental oxygen
/
Date stopped
Date started:
/
c. Ventilatory support
 Yes
Date started:
/
/
Check all that apply:
 Intubation
Date stopped:
Date started:
/
/
 ECMO
Date stopped:
Date started:
/
/
 CPAP
Date stopped:

 

5


No
/
/
/
/


Unknown

 No
/
/
 No
/
/
/
/
/
/


Unknown

Unknown

 

UAC Respiratory Disease Cluster
Hospitalization Case Investigation Form
Alien Number
 BiPAP

Date started:

/

d. Vasopressor medications (e.g. dopamine, epinephrine)
Date started:
/
/
e. Dialysis (Acute)
Date started:
/
/
f. Resuscitation, CPR

Yes, date started:
g. Acute respiratory distress syndrome (ARDS)

Yes, date started:
h. Disseminated intravascular coagulopathy (DIC)

Yes, date started:
i. Hemophagocytic syndrome

Yes, date started:
j. Bronchiolitis

Yes, date started:
k. Pneumonia

Yes, date started:
l. Stroke (Acute)

Yes, date started:
m. Sepsis

Yes, date started:
n. Shock

Yes, date started:
Type: 
hypovolemic

cardiogenic

septic

toxic
o. Acute myocarditis

Yes, date started:
p. Acute myocardial dysfunction

Yes, date started:
q. Acute myocardial infarction

Yes, date started:
r. Seizures

Yes, date started:
s. Reye’s syndrome

Yes, date started:
t. Acute encephalitis / encephalopathy

Yes, date started:
u. Guillain-Barre syndrome

Yes, date started:
v. Rhabdomyolysis

Yes, date started:
w. Acute liver impairment

Yes, date started:
x. Acute renal failure

Yes, date started:
y. Other, specify:

Yes, date started:
z. Other, specify:

Yes, date started:

/

Date stopped:

/

/
/
/
/
/
/
/
/
/

/
/
/
/
/
/
/
/
/

 Yes
Date stopped
 Yes
Date stopped
stopped:
/_
stopped:
/_
stopped:
/
stopped:
/_
stopped:
/_
stopped:
/_
stopped:
/_
stopped:
/_
stopped:
/_

/
/
/
/
/
/
/
/
/
/
/
/

/
/
/
/
/
/
/
/
/
/
/
/

stopped:
stopped:
stopped:
stopped:
stopped:
stopped:
stopped:
stopped:
stopped:
stopped:
stopped:
stopped:

/_
/_
/_
/_
/_
/_
/_
/_
/_
/_
/_
/_

/

Unknown

No

/
/

No
/
/
/
/
/

/
/
/
/
/
/
/
/
/
/
/
/
/

/
/
/
/
/


Unknown
 No
 No
 No

No

No

No

No

No

No


No

No

No

No

No

No

No

No

No

No

 Unknown
 Unknown
 Unknown
 Unknown
 Unknown
 Unknown
 Unknown
 Unknown
 Unknown
 Unknown
 Unknown
 Unknown
 Unknown
 Unknown
 Unknown
 Unknown
 Unknown
 Unknown
 Unknown

XII. Outcomes

Yes, date

57. Did the patient die during this illness?

/_


No (skip to Q.62)

/_


Unknown (skip to Q.62)

58. What was the location of death?

Home

Hospital

ER

Hospice

Other, specify
59. . Did the patient have a DNR (do not resuscitate) order?

Yes

No

Unknown
60. Was an autopsy performed?

Yes (please attach a copy of the autopsy form to this report if available)

No

Unknown
61. What were the causes of death (immediate and underlying) in order of appearance on the death certificate or medical record?
1.

4.

7.

2.

5.

8.

3.

6.

9.

62. Has the patient been discharged from the hospital?

Yes, date
/_
/

No

Unknown
63. If yes, please indicate to where:

Home

Other hospital

Hospice

Rehabilitation Facility
 Other long-term care facility

Other, specify:
63. If no, please indicate status:

Hospitalized on ward

Hospitalized in ICU 
Died
64. If patient was pregnant, please indicate pregnancy status at discharge or final update:
 Still

Uncomplicated labor/delivery 
Complicated labor/delivery
pregnant
Describe
64. If pregnancy resulted in delivery, please indicate neonatal outcome: Birth date:
/_
 Healthy newborn


Ill newborn, describe:

 
 
 
XIII. Additional Comments
66. Additional Comments:

 
 


Fetal loss
/_
Date

6

/_

/


Newborn died: Date

65. Additional notes regarding discharge:


Unknown

/_

/_


Unknown

 

UAC Respiratory Disease Cluster
Hospitalization Case Investigation Form
Alien Number

 

7

Form Approved
OMB No. 0920-1011
Exp. Date 03/31/2017

 
Verbal Consent / Assent Script 
 
 
Hi, my name is _______________.  I’m working with the health department and this shelter to find out 
what has been making some children here sick with fever and cough.  We’d like to ask you some 
questions about the symptoms you’ve had in the last week.  We will swab your nose and throat to test 
for any germs that might be making you sick.  You don’t have to answer our questions or allow us to 
swab your nose and throat; you can decide if you want to talk to us and let us swab you.  We can answer 
any questions that you have about the study and procedures. Do you have any questions? 
 
May I ask you some questions now?     
 
□ Yes   
□ No 
 
(Complete questionnaire) 
 
May I swab your nose and throat now?    
 
□ Yes   
□ No 
 
 
 
 
 
 
 
             Place sticker with Alien number here,  
 
 
DO NOT PUT CHILD’s NAME ON THIS FORM 
 
 
 
 
 
 
Verbal consent obtained by:  ___________________________________ Date:  ____________ 
 
 

 

Public reporting burden of this collection of information is estimated to average 10 minutes per response, including the time for
reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing
the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of
information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other
aspect of this collection of information including suggestions for reducing this burden to CDC/ATSDR Reports Clearance Officer;
1600 Clifton Road NE, MS D-74 Atlanta, Georgia 30333; ATTN: PRA (0920-1011)

 

Form Approved
OMB No. 0920-1011
Exp. Date 03/31/2017

 
Consentimiento Verbal
El párrafo a continuación se leerá al entrevistado y las respuestas serán registradas por el
entrevistador:
Hola, me llamo_______________, estoy trabajando con el departamento de salud y este
refugio para tratar de entender por qué algunos niños de éste refugio se están enfermando con
fiebre y con tos. Nos gustaría hacerte algunas preguntas sobre los síntomas que has tenido la
semana pasada. Vamos a pasarte un hisopo por la nariz y por la garganta para detectar
algunos gérmenes que podrían estar enfermándote. No tienes que responder a nuestras
preguntas o dejarte pasar el hisopo si no quieres; o si quieres podemos hacerte las preguntas y
pasar un hisopo por la nariz y garganta. Podemos responder a cualquier pregunta que tengas
sobre este estudio y los procedimientos. Tienes alguna pregunta?
¿Puedo hacerte algunas preguntas ahora? □ Sí □ No
(Cuestionario completo)
¿Puedo pasar el hisopo por la nariz y garganta ahora? □ Sí □ No
 
             Place sticker with Alien number here,  
DO NOT PUT CHILD’s NAME ON THIS FORM 
 

El consentimiento verbal fue obtenido por: ________________________Fecha: ________
 

Public reporting burden of this collection of information is estimated to average 10 minutes per response, including the time for
reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing
the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of
information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other
aspect of this collection of information including suggestions for reducing this burden to CDC/ATSDR Reports Clearance Officer;
1600 Clifton Road NE, MS D-74 Atlanta, Georgia 30333; ATTN: PRA (0920-1011)

 


File Typeapplication/pdf
File Modified2014-10-27
File Created2014-10-27

© 2024 OMB.report | Privacy Policy